Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",6.527777761822027e-13,3.422010293672419,96.01318944841485,"['NPFFR2', 'GPR27', 'OXTR', 'NPFFR1', 'CHRM1', 'GPR68', 'GPR65', 'GPR22', 'HTR2B', 'ADRA1D', 'MC4R', 'CYSLTR2', 'ADORA3', 'GPR171', 'C3AR1', 'CMKLR1', 'PTGDR', 'GPR39', 'OR2H2', 'GPR37L1', 'AVPR1A', 'SSTR1', 'SSTR3', 'TRHR', 'CCKBR', 'ADORA2A', 'ADORA2B', 'FSHR', 'OR7A5', 'OR3A2', 'CX3CR1', 'GPR87', 'PTGER3', 'CXCR5', 'OPRL1', 'CXCR4', 'GPR83', 'ADRB1', 'ADRB2', 'MCHR1', 'P2RY6', 'CNR2', 'OR2AG1', 'P2RY1', 'RHO', 'DRD3', 'DRD5', 'CCR1', 'GPR17', 'GPR12', 'HTR1E', 'P2RY14', 'HTR1D', 'GPR52', 'GPR4', 'GPR3', 'GPR6', 'HTR5A', 'HCRTR2', 'HCRTR1', 'MAS1', 'OPN1SW', 'ACKR4', 'RGL4', 'OR7C1', 'GPR18', 'F2RL2']",3.7926388796185975e-10,0,0,67
2,TYROBP causal network in microglia WP3945,1.300337626062319e-10,5.842504207337597,132.99424944317445,"['CD84', 'RBM47', 'ITGAM', 'PLEK', 'ITGB2', 'GIMAP2', 'CAPG', 'TCIRG1', 'SLC1A5', 'SAMSN1', 'ZFP36L2', 'C3', 'LYL1', 'ADAP2', 'RGS1', 'ITGAX', 'SPP1', 'CYTL1', 'NCKAP1L', 'IL13RA1', 'IL10RA', 'RNASE6', 'LHFPL2', 'TNFRSF1B', 'RUNX3', 'APBB1IP', 'TYROBP', 'BIN2', 'ELF4', 'HCLS1', 'TMEM106A', 'C1QC']",3.777480803711037e-08,0,0,32
3,Microglia Pathogen Phagocytosis Pathway WP3937,1.4556877588242149e-08,6.545931208053691,118.12265268523043,"['C1QB', 'VAV3', 'LYN', 'C1QA', 'ITGAM', 'FCER1G', 'NCF1', 'SYK', 'NCF4', 'ITGB2', 'CYBB', 'TREM2', 'CYBA', 'PIK3R6', 'VAV1', 'HCK', 'TYROBP', 'PLCG2', 'NCKAP1L', 'PTPN6', 'FCGR1A', 'SIGLEC7', 'C1QC']",2.819181959589563e-06,0,0,23
4,Spinal Cord Injury WP2431,1.0526056983672735e-06,2.8081725901503156,38.65236668857758,"['C1QB', 'XYLT1', 'AQP4', 'CXCL1', 'PLA2G5', 'AIF1', 'RTN4', 'EGFR', 'AQP1', 'TNFSF13B', 'LGALS3', 'ACAN', 'GJA1', 'ZFP36', 'CHST11', 'PRB1', 'PTPRZ1', 'CCL2', 'SOX9', 'ROS1', 'MAPK3', 'NGFR', 'EGR1', 'IL1R1', 'BDNF', 'TNFSF13', 'LILRB2', 'PDYN', 'RHOC', 'GFAP', 'SELP', 'NR4A1', 'VCAN', 'FCGR2A', 'LEP', 'CDK2', 'CSPG4', 'LTB', 'VIM', 'TLR4']",0.0001528909776878465,0,0,40
5,Hematopoietic Stem Cell Differentiation WP2849,1.3862527487250143e-06,4.361381431767338,58.83026553898466,"['GYPA', 'NOTCH1', 'CSF1', 'LEF1', 'RHOH', 'CXCR4', 'NFATC2', 'IKZF1', 'GATA2', 'GATA1', 'VAV1', 'ABO', 'FLI1', 'RUNX1', 'LYL1', 'MUC1', 'TPO', 'IL5', 'TRIM29', 'PIM1', 'FOSB', 'NCKAP1L', 'CD34']",0.00015729837850937448,0,0,23
6,Vitamin D Receptor Pathway WP2877,1.6244238744513716e-06,2.4633776307534365,32.83770409077872,"['COLEC11', 'CEBPA', 'CDKN1A', 'STEAP4', 'ITGAM', 'COL13A1', 'LRP5', 'TNFAIP3', 'TNFRSF11B', 'ADRB2', 'CYP3A4', 'CYP3A5', 'FOXO1', 'THBD', 'SULT1C2', 'IL1RL1', 'CASP5', 'CLMN', 'ALOX5', 'CREG2', 'BTLA', 'TIMP2', 'SPP1', 'SOSTDC1', 'LGALS9', 'CD14', 'EPHB4', 'HLA-DQA1', 'CDKN2D', 'LRRC25', 'IGFBP5', 'VDR', 'CDKN2A', 'MX2', 'NFATC2', 'G0S2', 'KLF4', 'CEACAM1', 'CYP24A1', 'TRPV6', 'BCL6', 'CDK2', 'PNOC', 'S100A6', 'IRF8', 'S100A4', 'S100A9', 'S100A8']",0.00015729837850937448,0,0,48
7,Complement system WP2806,3.652091316951945e-06,3.0378099405362953,38.03402019065092,"['FCN1', 'SELPLG', 'CFH', 'C1R', 'CFI', 'C5AR1', 'ITGB2', 'ICAM2', 'F13A1', 'C4BPA', 'PLG', 'LRP2', 'THBS1', 'C3', 'FCGR3A', 'C7', 'C9', 'C3AR1', 'ITGAX', 'SPP1', 'VSIG4', 'PRNP', 'CR1', 'CD93', 'F12', 'F11', 'SELE', 'SELP', 'ALB', 'MASP2', 'PTX3', 'TLR2']",0.00030312357930701146,0,0,32
8,Complement and Coagulation Cascades WP558,1.1904141373297085e-05,3.608088405461699,40.9107585237157,"['C1QB', 'C1QA', 'SERPINA1', 'CR1', 'VWF', 'CFH', 'SERPIND1', 'C1R', 'F12', 'SERPINF2', 'C5AR1', 'CFI', 'PLG', 'TFPI', 'F5', 'C3', 'THBD', 'F7', 'C7', 'C9', 'C3AR1', 'MASP2', 'C1QC']",0.0008645382672357008,0,0,23
9,Peptide GPCRs WP24,7.208856783142666e-05,3.2921321029626034,31.399088810789554,"['CX3CR1', 'CCR1', 'OXTR', 'C5AR1', 'TACR2', 'CXCR5', 'OPRL1', 'CXCR4', 'SSTR1', 'AVPR1A', 'SSTR3', 'TSHR', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'CCKBR', 'FSHR', 'C3AR1', 'GNRHR', 'TAC4']",0.004653717545562099,0,0,21
10,Macrophage markers WP4146,0.0001616997015323189,15.869158878504672,138.53410134538052,"['CD86', 'CD74', 'CD163', 'CD83', 'CD14', 'LYZ', 'CD68']",0.00939475265902773,0,0,7
11,Apoptosis Modulation and Signaling WP1772,0.0003731586293513858,2.314450382850199,18.26913018006006,"['BCL2A1', 'TNFRSF11B', 'CASP7', 'BCL2L10', 'CASP6', 'CASP10', 'BAG3', 'CASP4', 'PEA15', 'CASP1', 'TNFSF10', 'PMAIP1', 'MAPK3', 'JUN', 'ENDOG', 'CRADD', 'IL1R1', 'BIK', 'CDKN2A', 'IL1R2', 'TNFRSF10C', 'TNFRSF10A', 'TNFRSF1B', 'TNFRSF10D', 'NFKBIA', 'TOLLIP', 'CYCS', 'BCL2L2', 'HSPA1A']",0.019709560332105015,0,0,29
12,Heart Development WP1591,0.0004696878353226998,3.7385314781650365,28.65002013540079,"['TBX1', 'FOXC1', 'NOTCH1', 'VEGFC', 'NFATC2', 'NFATC1', 'TBX2', 'FGF8', 'HEY1', 'ERBB3', 'HEY2', 'BHLHE40', 'SMYD1', 'FGF10']",0.02274071936020738,0,0,14
13,White fat cell differentiation WP4149,0.0008139752125633053,3.6875,26.231328624092953,"['CEBPA', 'CEBPB', 'TCF7L1', 'EGR2', 'CEBPD', 'EBF1', 'NR2F2', 'GATA2', 'KLF4', 'KLF15', 'FOXO1', 'MECOM', 'ZNF423']",0.032466286674464905,0,0,13
14,"GPCRs, Other WP117",0.0008695608185064464,2.4308490713282347,17.131462989716173,"['GPR17', 'ADGRV1', 'GPR88', 'GPR55', 'ADRA1D', 'GPR83', 'ADRB2', 'GPR84', 'ADGRE2', 'GPR162', 'GPR132', 'PROKR2', 'CCKBR', 'ADORA2A', 'ADORA3', 'ADGRE3', 'FSHR', 'HRH4', 'GNRHR', 'OR10A2', 'LGR6', 'DRD3', 'GPR18']",0.032466286674464905,0,0,23
15,Proximal tubule transport WP4917,0.0009545692270582314,2.696946213136729,18.755239255566792,"['SLC47A2', 'ATP6V1G1', 'SLC22A6', 'ABCC2', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'SLC5A2', 'SLC4A4', 'AQP1', 'FXYD2', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0D2', 'ATP6V0C', 'ATP6V1D', 'ABCG2', 'ATP6V1B1']",0.032466286674464905,0,0,19
16,Thyroxine (Thyroid Hormone) Production WP1981,0.0009879147069045784,22.656771180787192,156.78291246118636,"['TPO', 'TG', 'TRH', 'CGA', 'TSHR']",0.032466286674464905,0,0,5
17,Role of Osx and miRNAs in tooth development WP3971,0.0010536065513524558,7.933411214953271,54.38778769022053,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'ALPL', 'KLF4', 'BMP7', 'DKK1']",0.032466286674464905,0,0,7
18,Gastric acid production WP2596,0.0010720618635561695,inf,inf,"['GRP', 'CCK', 'VIP', 'MUC6']",0.032466286674464905,0,0,4
19,Glucocorticoid Receptor Pathway WP2880,0.0010815621249145818,2.4381243812438123,16.650801990244695,"['SRGN', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'CAVIN2', 'PLK2', 'AMIGO2', 'TNFAIP3', 'TGFBR3', 'PRRG4', 'THBD', 'FGD4', 'RGS2', 'ZIC2', 'B3GNT5', 'ENC1', 'ALOX5AP', 'BHLHE40', 'CCL2', 'STOM', 'ANGPTL4']",0.032466286674464905,0,0,22
20,Nuclear Receptors Meta-Pathway WP2882,0.001144053072370375,1.5827973438097556,10.72056813990332,"['SERPINA1', 'SRXN1', 'TNFAIP3', 'SLC2A3', 'SLC7A11', 'SLC2A5', 'THBD', 'RGS2', 'ZIC2', 'SLCO2B1', 'ENC1', 'PDK4', 'CYP1B1', 'SLC39A3', 'SRGN', 'ABCC3', 'HSP90AA1', 'SERPINB2', 'ABCC2', 'SLC2A10', 'GPX3', 'HGF', 'MYOF', 'CYP4A11', 'SLC39A11', 'SLC39A12', 'CES4A', 'TGFBR2', 'TGFBR3', 'KAT2B', 'CYP2A6', 'B3GNT5', 'ANGPTL4', 'EPHA2', 'FKBP5', 'AMIGO2', 'SLC5A11', 'SLC5A2', 'ABCB11', 'CYP2C19', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'EGFR', 'FOXO1', 'CYP3A7', 'PRRG4', 'FGD4', 'SLCO1B1', 'DNAJB1', 'HMOX1', 'CCL2', 'STOM', 'HES1', 'IP6K3', 'CBR3', 'EGR1', 'JUN', 'GADD45B', 'SLC10A1', 'CAVIN2', 'VDR', 'PLK2', 'SOD3', 'SLC2A9', 'BHLHE40', 'ALOX5AP', 'HSPA1A']",0.032466286674464905,0,0,68
21,Blood Clotting Cascade WP272,0.0012293602527336108,5.1019539078156315,34.18952660659737,"['F7', 'F8A1', 'SERPINB2', 'VWF', 'F12', 'SERPINF2', 'F11', 'PLG', 'F5']",0.032466286674464905,0,0,9
22,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.0012293602527336108,5.1019539078156315,34.18952660659737,"['TLR1', 'JUN', 'TIFA', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR4', 'TLR2']",0.032466286674464905,0,0,9
23,Glycolysis and Gluconeogenesis WP534,0.0013341393378508786,2.9056042852360227,19.233557160511126,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A3', 'ENO2', 'SLC2A5', 'HK2', 'GCK', 'LDHC', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA']",0.03370151979527654,0,0,16
24,Allograft Rejection WP2328,0.0017075784146255856,2.3848591549295777,15.197941959338994,"['CD86', 'C1QB', 'PDGFRA', 'C1QA', 'HLA-DRB5', 'CD80', 'CXCR5', 'CXCL13', 'HLA-E', 'C3', 'CASP7', 'IL5', 'C7', 'GNLY', 'C9', 'HLA-DRA', 'VIM', 'HLA-DOA', 'HLA-DQA1', 'HLA-DPA1', 'C1QC']",0.03979579139345941,0,0,21
25,Selenium Micronutrient Network WP15,0.001712383450665207,2.2257023655383605,14.177432608636291,"['SERPINA3', 'GPX4', 'GPX3', 'DIO3', 'PLG', 'KMO', 'SOD3', 'SELENOH', 'PRDX3', 'F7', 'SELENOM', 'KYNU', 'RFK', 'ALOX5', 'SELENOP', 'ALOX5AP', 'ALB', 'SELENOW', 'PNPO', 'SELENOV', 'CCL2', 'SAA2', 'SEPHS2', 'XDH']",0.03979579139345941,0,0,24
26,Drug Induction of Bile Acid Pathway WP2289,0.0021843438633013116,5.181588361554972,31.74468909770492,"['ABCC3', 'SLCO1B1', 'ABCC2', 'VDR', 'SLC10A1', 'SLC51A', 'CYP3A4', 'ABCB11']",0.04700384387326156,0,0,8
27,Platelet-mediated interactions with vascular and circulating cells WP4462,0.0021843438633013116,5.181588361554972,31.74468909770492,"['SELP', 'VCAM1', 'SELPLG', 'CCL2', 'TLR7', 'SELE', 'TLR4', 'TLR2']",0.04700384387326156,0,0,8
28,Inflammatory Response Pathway WP453,0.0028720211498730014,3.779374095110814,22.119691158519707,"['CD86', 'ZAP70', 'COL3A1', 'IL4R', 'COL1A2', 'IL5', 'LAMB2', 'CD80', 'TNFRSF1B', 'THBS1']",0.059594438859864776,0,0,10
29,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.003478488042466906,1.7459791847650195,9.884263244256296,"['TPH1', 'DLX2', 'CEBPB', 'YWHAB', 'CDCA7L', 'SLC1A3', 'ATP1A3', 'AQP4', 'GATA2', 'FOXM1', 'NEUROD1', 'GJA1', 'HES1', 'SCN3B', 'TAC1', 'YWHAG', 'HES5', 'YWHAH', 'NKX3-1', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'TSPYL1', 'CAV3', 'BDNF', 'SSTR1', 'RUNX3', 'GCK', 'ADCYAP1', 'PRKAR1A', 'SST', 'PAH', 'BHLHE40', 'CHRFAM7A', 'ALDOA', 'SCN4B', 'SLC25A4']",0.06968970871287146,0,0,38
30,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.005858075347739866,4.029530699313671,20.711522523589306,"['TCF7L1', 'VCAM1', 'NOTCH1', 'EPAS1', 'LEF1', 'TNC', 'CXCR4', 'CYTIP']",0.11272661795453102,0,0,8
31,Pregnane X receptor pathway WP2876,0.006142037777381057,3.238986205909026,16.49485696199406,"['ABCC3', 'SLCO1B1', 'HSP90AA1', 'CYP2A6', 'ABCC2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1', 'CYP3A7']",0.11272661795453102,0,0,10
32,Oxidation by Cytochrome P450 WP43,0.006504220656659327,2.4307946069994264,12.239789761645442,"['CYP2J2', 'CYP4A11', 'CYP3A4', 'CYP2C19', 'CYP4F11', 'CYP3A5', 'CYP2C18', 'CYP3A7', 'CYP27A1', 'CYP39A1', 'CYP26B1', 'CYP2A6', 'CYP24A1', 'CYP11A1', 'CYP1B1']",0.11272661795453102,0,0,15
33,Regulation of toll-like receptor signaling pathway WP1449,0.00658096292672076,1.7522638517719482,8.802627482444251,"['CD86', 'CD80', 'PELI3', 'PELI2', 'LY96', 'TNFAIP3', 'PIK3R5', 'TIFA', 'SPP1', 'MAP3K8', 'CD14', 'MAPK3', 'JUN', 'TICAM2', 'CISH', 'SYK', 'CD180', 'IRAK3', 'SMAD6', 'NFKBIA', 'TLR1', 'TOLLIP', 'BTK', 'IRF7', 'TLR9', 'TLR7', 'PTPN6', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'TLR2']",0.11272661795453102,0,0,32
34,Nephrogenesis WP5052,0.006596738400093037,4.53237650200267,22.757877944744354,"['NOTCH2', 'MEIS1', 'FOXD1', 'FGF8', 'ALDH1A2', 'BMP7', 'PAX2']",0.11272661795453102,0,0,7
35,Differentiation of white and brown adipocyte WP2895,0.007429532299593046,3.400300601202405,16.6692676922962,"['PLAC8', 'CEBPA', 'CEBPB', 'LEP', 'ZIC1', 'PRDM16', 'EBF3', 'ZNF423', 'BMP7']",0.12333023617324457,0,0,9
36,Pre-implantation embryo WP3527,0.008159206899193612,2.4428030985408036,11.746483275565394,"['EGR1', 'DLX2', 'TCF7L1', 'FOXD1', 'HMGA1', 'ATP1A1', 'GATA2', 'KLF4', 'AQP3', 'ZFP36L2', 'TBX3', 'ZFP36', 'ARGFX', 'FOSB']",0.13168053356754136,0,0,14
37,Myometrial relaxation and contraction pathways WP289,0.008454790694782877,1.6298323204683574,7.779225606882948,"['RYR1', 'RGS18', 'OXTR', 'RGS14', 'YWHAB', 'LPAR1', 'ADCY4', 'ATP2A2', 'RXFP2', 'ETS2', 'RYR3', 'ACTG1', 'RGS4', 'CNN2', 'GJA1', 'RGS2', 'GNG3', 'RGS1', 'PLCG2', 'RGS20', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP2', 'GNG11', 'ACTA2', 'ACTA1', 'ACTC1', 'PRKAR1A', 'CRH', 'RGS10', 'CALM3', 'CALM1', 'CALM2']",0.13276306469375276,0,0,38
38,Complement Activation WP545,0.008891832081060268,3.626310517529215,17.12569443570439,"['C1QB', 'C3', 'C1QA', 'C7', 'C1R', 'C9', 'MASP2', 'C1QC']",0.13595143260778988,0,0,8
39,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.009421618465961288,2.7712418300653594,12.927145874738157,"['IFIH1', 'OAS1', 'OAS2', 'OAS3', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR4', 'TLR3', 'TLR2']",0.14035795714675664,0,0,11
40,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.011750099796447882,2.8336952890076845,12.592640203639283,"['RAB3B', 'FGD4', 'EGR2', 'RAB3A', 'RAB25', 'SH3TC2', 'HSPB1', 'NEFL', 'MFN2', 'RAB11A']",0.1568570120290978,0,0,10
41,EDA signaling in hair follicle development WP3930,0.011923860250409141,4.531197864531197,20.069644217512582,"['EDA', 'PTCH1', 'SOSTDC1', 'LTB', 'GLI1', 'DKK1']",0.1568570120290978,0,0,6
42,Transcriptional cascade regulating adipogenesis WP4211,0.011923860250409141,4.531197864531197,20.069644217512582,"['CEBPA', 'CEBPB', 'EGR2', 'CEBPD', 'GATA2', 'KLF15']",0.1568570120290978,0,0,6
43,Sleep regulation WP3591,0.012489811813916873,2.6251934984520124,11.50580838062985,"['CHRNB2', 'OXTR', 'AHCY', 'STAR', 'ADORA2A', 'CRH', 'UTS2', 'DRD3', 'HCRTR2', 'PTGDR', 'HCRTR1']",0.1568570120290978,0,0,11
44,Toll-like Receptor Signaling related to MyD88 WP3858,0.012489811813916873,2.6251934984520124,11.50580838062985,"['TLR1', 'TICAM2', 'TOLLIP', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'TLR2']",0.1568570120290978,0,0,11
45,Fatty Acid Omega Oxidation WP206,0.012781402079717067,5.6629419613075385,24.68909121705398,"['CYP2A6', 'ADH1B', 'CYP4A11', 'ALDH1A1', 'CYP3A4']",0.1568570120290978,0,0,5
46,Irinotecan pathway WP229,0.012781402079717067,5.6629419613075385,24.68909121705398,"['SLCO1B1', 'ABCC2', 'CYP3A4', 'CYP3A5', 'ABCG2']",0.1568570120290978,0,0,5
47,Nucleotide GPCRs WP80,0.012781402079717067,5.6629419613075385,24.68909121705398,"['P2RY6', 'ADORA2A', 'ADORA2B', 'ADORA3', 'P2RY1']",0.1568570120290978,0,0,5
48,Kynurenine Pathway and links to Cellular Senescence WP5044,0.012958926983471076,3.296403096069206,14.326070235739616,"['CDKN1A', 'IL1R2', 'HAAO', 'KYNU', 'KMO', 'TLR4', 'FOXO1', 'ACMSD']",0.1568570120290978,0,0,8
49,Constitutive Androstane Receptor Pathway WP2875,0.01464687949618854,2.9141139421700544,12.307841742174539,"['ABCC3', 'HSP90AA1', 'CYP2A6', 'ABCC2', 'CYP4A11', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1']",0.1736701425976641,0,0,9
50,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.016260530359406906,2.49375,10.271792553924495,"['ITGAM', 'TICAM2', 'TYROBP', 'SYK', 'ITGB2', 'LY96', 'CCL2', 'PLG', 'CD14', 'TLR4', 'TLR3']",0.18759237422448194,0,0,11
51,Genes controlling nephrogenesis WP4823,0.016466800491305642,2.3658802494439843,9.715271988245354,"['NOTCH2', 'FOXC1', 'EMX2', 'FGF8', 'FOXD1', 'EYA1', 'LAMB2', 'ITGA8', 'CXCR4', 'ETV4', 'GLI3', 'PAX2']",0.18759237422448194,0,0,12
52,Farnesoid X receptor pathway WP2879,0.01879823297797995,3.8835978835978837,15.43338848998363,"['SLC10A1', 'SLCO2B1', 'CYP3A4', 'ABCB11', 'IP6K3', 'FKBP5']",0.21003410308089135,0,0,6
53,TGF-beta Receptor Signaling WP560,0.019204145934541044,2.061731775587197,8.149260990248218,"['JUN', 'FST', 'LEF1', 'SMAD6', 'RUNX3', 'LTBP1', 'THBS1', 'TGFBR2', 'TGFBR3', 'BAMBI', 'SPP1', 'ZNF423', 'HRAS', 'ENG', 'MAPK3']",0.21052092052770466,0,0,15
54,Gene regulatory network modelling somitogenesis  WP2854,0.021793211794402096,4.530020013342228,17.332566621131893,"['LFNG', 'NOTCH1', 'FGF8', 'HES1', 'TBX6']",0.2302155645917749,0,0,5
55,Tamoxifen metabolism WP691,0.021793211794402096,4.530020013342228,17.332566621131893,"['CYP2A6', 'CYP1B1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.2302155645917749,0,0,5
56,Codeine and Morphine Metabolism WP1604,0.023564988926948176,6.03890185617428,22.633763022964477,"['ABCC3', 'SLCO1B1', 'ABCC2', 'CYP3A4']",0.2401975187115244,0,0,4
57,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.023564988926948176,6.03890185617428,22.633763022964477,"['CD86', 'IL5', 'CD80', 'VIP']",0.2401975187115244,0,0,4
58,Calcium Regulation in the Cardiac Cell WP536,0.025787960930161394,1.5002087179154182,5.48753474817228,"['RYR1', 'RGS18', 'GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'ADCY4', 'ATP2A2', 'ADRB1', 'ADRA1D', 'ADRB2', 'RYR3', 'RGS4', 'GJA1', 'RGS2', 'GNG3', 'PLN', 'RGS1', 'GJA4', 'RGS20', 'YWHAG', 'YWHAH', 'PRKCH', 'ATP1B1', 'GNG11', 'GJD2', 'SLC8A3', 'PRKAR1A', 'GJB3', 'FXYD2', 'GJB6', 'RGS10', 'CALM3', 'CASQ1', 'CALM1', 'CALM2']",0.2583242293176512,0,0,36
59,Cells and molecules involved in local acute inflammatory response  WP4493,0.027949369099731752,3.3978978978978978,12.155506239780307,"['SELP', 'C3', 'VCAM1', 'SELPLG', 'C7', 'ITGB2']",0.27064305744906914,0,0,6
60,Cytokines and Inflammatory Response WP530,0.027949369099731752,3.3978978978978978,12.155506239780307,"['IL5', 'CSF1', 'IL15', 'IL7', 'HLA-DRA', 'CXCL1']",0.27064305744906914,0,0,6
61,Monoamine GPCRs WP58,0.03335163477187774,2.2662880053458068,7.7068488814143485,"['CHRM1', 'HTR1E', 'HTR1D', 'HTR2B', 'ADRB1', 'ADRA1D', 'ADRB2', 'HTR5A', 'DRD3', 'DRD5']",0.3146370648033693,0,0,10
62,Purinergic signaling WP4900,0.033575728085729596,2.3993280679005067,8.143203938298589,"['P2RY8', 'GNAZ', 'P2RY6', 'ADORA2A', 'GNAT3', 'ADORA2B', 'ADORA3', 'P2RY14', 'P2RY1']",0.3146370648033693,0,0,9
63,Hippo-Merlin Signaling Dysregulation WP4541,0.037447048026103505,1.531169383416017,5.029627139371082,"['CSF1R', 'FLT1', 'ITGAM', 'ITGB5', 'ITGB4', 'ITGB2', 'FOXM1', 'EGFR', 'CDH5', 'CDH20', 'ITGAX', 'ITGB8', 'HRAS', 'TEAD2', 'TEAD3', 'NTRK1', 'PDGFRA', 'NGFR', 'LATS2', 'PRKAR1A', 'ITGA10', 'ITGA8', 'ITGA6', 'FGFR4', 'CDH17', 'CD44', 'EPHA2', 'CDH19']",0.3453449984629545,0,0,28
64,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.038738331575427526,1.83829914251601,5.976173906771301,"['JUN', 'FST', 'LEF1', 'SMAD6', 'RUNX3', 'LTBP1', 'THBS1', 'TGFBR2', 'TGFBR3', 'BAMBI', 'SPP1', 'ZNF423', 'HRAS', 'ENG', 'MAPK3']",0.351671416333178,0,0,15
65,ERK Pathway in Huntington's Disease WP3853,0.03961056837863709,3.0201312423534645,9.750974877445886,"['CASP7', 'RPS6KA5', 'BDNF', 'ELK1', 'HRAS', 'EGFR']",0.3540575419690485,0,0,6
66,Breast cancer pathway WP4262,0.04349114473773609,1.4425889959487916,4.522802035177138,"['SHC4', 'NOTCH2', 'NOTCH3', 'CDKN1A', 'NOTCH1', 'SHC3', 'LEF1', 'LRP5', 'FGF2', 'EGFR', 'FRAT1', 'FRAT2', 'FGF8', 'HEY1', 'HEY2', 'HES1', 'HRAS', 'HES5', 'SKP1', 'MAPK3', 'WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'GADD45B', 'CSNK2A3', 'FZD9', 'WNT16', 'FGF17', 'SFRP4', 'HEYL', 'RAD51', 'PGR', 'FGF10']",0.3828538650397677,0,0,34
67,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.044353662519465695,6.792,21.160883462004257,"['MAS1', 'REN', 'AGT']",0.38461907348969504,0,0,3
68,NRF2 pathway WP2884,0.047243238700136324,1.4787824063229638,4.513903044108808,"['SERPINA1', 'SRXN1', 'SLC5A11', 'SLC2A3', 'SLC7A11', 'SLC5A2', 'SLC2A5', 'SLC5A3', 'DNAJB1', 'HMOX1', 'SLC39A3', 'CBR3', 'ABCC3', 'EGR1', 'HSP90AA1', 'ABCC2', 'GPX3', 'SLC2A10', 'HGF', 'CYP4A11', 'SLC39A11', 'SLC39A12', 'SOD3', 'CES4A', 'TGFBR2', 'SLC2A9', 'CYP2A6', 'EPHA2', 'HSPA1A']",0.38505249255090945,0,0,29
69,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.04791377392920089,1.6198936832527178,4.921807633419331,"['TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'LRP5', 'FZD9', 'WNT16', 'KLF4', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'FRAT2', 'SFRP2', 'WIF1', 'NOTUM']",0.38505249255090945,0,0,20
70,Tryptophan metabolism WP465,0.04856311512181711,1.994264705882353,6.032433329197763,"['CYP2J2', 'TPH1', 'HAAO', 'KYNU', 'ALDH1A2', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD']",0.38505249255090945,0,0,11
71,Endochondral Ossification with Skeletal Dysplasias WP4808,0.04905406486297529,1.7273582348908763,5.207695269943126,"['HMGCS1', 'PTCH1', 'PTH1R', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'ACAN', 'SCIN', 'CHST11', 'SERPINH1', 'SPP1', 'ALPL', 'SOX9', 'CALM1', 'CALM2']",0.38505249255090945,0,0,16
72,Endochondral Ossification WP474,0.04905406486297529,1.7273582348908763,5.207695269943126,"['HMGCS1', 'PTCH1', 'PTH1R', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'ACAN', 'SCIN', 'CHST11', 'SERPINH1', 'SPP1', 'ALPL', 'SOX9', 'CALM1', 'CALM2']",0.38505249255090945,0,0,16
73,Computational Model of Aerobic Glycolysis WP4629,0.04993477724582356,3.2352520728104452,9.696172043567062,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA']",0.38505249255090945,0,0,5
74,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.04993477724582356,3.2352520728104452,9.696172043567062,"['ZAP70', 'HLA-DRB5', 'CD8B', 'HLA-DRA', 'CD247']",0.38505249255090945,0,0,5
75,Toll-like Receptor Signaling Pathway WP75,0.05021419230697757,1.5875586854460093,4.74911445845001,"['CD86', 'JUN', 'TICAM2', 'CD80', 'LY96', 'PIK3R5', 'NFKBIA', 'TLR1', 'TOLLIP', 'IRF7', 'TLR9', 'SPP1', 'MAP3K8', 'TLR7', 'CD14', 'TLR6', 'TLR5', 'TLR4', 'TLR3', 'TLR2', 'MAPK3']",0.38505249255090945,0,0,21
76,PI3K-Akt signaling pathway WP4172,0.050765270467995054,1.2815291245036746,3.8196524183566782,"['CDKN1A', 'CHRM1', 'CSF3R', 'FLT1', 'CSF1', 'ITGB5', 'ITGB4', 'TNC', 'FGF2', 'GYS2', 'FGF8', 'CREB3L1', 'TNR', 'ITGB8', 'HRAS', 'PDGFRA', 'HSP90AA1', 'IL4R', 'SYK', 'VWF', 'HGF', 'OSMR', 'PRLR', 'COL4A6', 'ITGA8', 'COL4A5', 'ITGA6', 'COL6A6', 'SGK1', 'TLR4', 'EPHA2', 'TLR2', 'CSF1R', 'PHLPP1', 'PKN3', 'LPAR1', 'LPAR3', 'THBS1', 'PIK3R6', 'EGFR', 'THBS4', 'PIK3R5', 'GNG3', 'RELN', 'SPP1', 'MAPK3', 'NTRK1', 'NGFR', 'ANGPT2', 'LAMB3', 'BDNF', 'LAMB2', 'VEGFC', 'GNG11', 'FGF17', 'EFNA3', 'COL1A2', 'IL7', 'ITGA10', 'CDK2', 'COL9A1', 'FGFR4', 'PIK3AP1', 'FGF10']",0.38505249255090945,0,0,64
77,Lung fibrosis WP3624,0.051524573300262846,1.8415760869565216,5.46155563338501,"['CEBPB', 'SERPINA1', 'HGF', 'MMP2', 'FGF2', 'BMP7', 'CYSLTR2', 'IL5', 'TERT', 'SPP1', 'HMOX1', 'CCL2', 'PTX3']",0.38505249255090945,0,0,13
78,Ovarian infertility WP34,0.05292372402720243,2.146450796329501,6.308211911010233,"['EGR1', 'CEBPB', 'VDR', 'FSHR', 'GJA4', 'MSH5', 'PGR', 'BMPR1B', 'PRLR']",0.38505249255090945,0,0,9
79,Dopaminergic Neurogenesis WP2855,0.05393941654381821,2.717917917917918,7.936031617892714,"['NEUROD1', 'FGF8', 'ALDH1A1', 'GLI1', 'SLC18A2', 'GLI2']",0.38505249255090945,0,0,6
80,B Cell Receptor Signaling Pathway WP23,0.054236999979778065,1.5343170153967627,4.471601153797445,"['LYN', 'JUN', 'GSK3A', 'SYK', 'GAB1', 'DAPP1', 'NFATC2', 'ELK1', 'FOXO1', 'VAV1', 'NFKBIA', 'PTPRC', 'BCL6', 'INPP5D', 'BTK', 'PLCG2', 'BLNK', 'HCLS1', 'PTPN6', 'PIK3AP1', 'HRAS', 'CARD11', 'CD22']",0.38505249255090945,0,0,23
81,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.054433499202834836,2.2654424040066776,6.594194292626205,"['NFKBIA', 'ZAP70', 'GSK3A', 'CD8B', 'NFATC2', 'PTPN6', 'CALM1', 'CALM2']",0.38505249255090945,0,0,8
82,Imatinib and Chronic Myeloid Leukemia WP3640,0.05500749893584421,2.439432063263839,7.075050072535969,"['PDGFRA', 'CSF1R', 'LYL1', 'SPRED2', 'FLT1', 'PIM1', 'ABCG2']",0.38505249255090945,0,0,7
83,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.05500749893584421,2.439432063263839,7.075050072535969,"['CD86', 'LDHA', 'CYP24A1', 'VDR', 'CD80', 'HLA-DRA', 'SLC2A3']",0.38505249255090945,0,0,7
84,Metapathway biotransformation Phase I and II WP702,0.059143278321070705,1.4209966420598992,4.018283409446355,"['GLYAT', 'CYP2C19', 'CYP3A4', 'CYP2C18', 'CYP3A5', 'NAA80', 'CYP3A7', 'SULT1C2', 'CYP26B1', 'CHST11', 'CYP11A1', 'CYP1B1', 'CHST13', 'CHST14', 'GAL3ST2', 'SULT4A1', 'CYP2J2', 'GPX4', 'GPX3', 'EPHX1', 'FMO2', 'CYP4F11', 'HS3ST4', 'CYP27A1', 'CYP39A1', 'SULT1B1', 'CYP2A6', 'CYP24A1', 'NAT8L', 'CHST2', 'CHST3']",0.40868057048209716,0,0,31
85,Folate Metabolism WP176,0.060360108301210004,1.785638998682477,5.013050870789416,"['SERPINA3', 'AHCY', 'CSF1', 'GPX4', 'GPX3', 'PLG', 'SOD3', 'F7', 'RFK', 'ALB', 'CCL2', 'SAA2', 'FOLR2']",0.40868057048209716,0,0,13
86,Bile acids synthesis and enterohepatic circulation  WP4389,0.0626033920359839,3.622807602534178,10.038567342026365,"['SLC10A1', 'FGFR4', 'ABCB11', 'MAPK3']",0.40868057048209716,0,0,4
87,PTF1A related regulatory pathway WP4147,0.0626033920359839,3.622807602534178,10.038567342026365,"['KAT2B', 'NOTCH1', 'HES1', 'FGF10']",0.40868057048209716,0,0,4
88,Tgif disruption of Shh signaling WP3674,0.0626033920359839,3.622807602534178,10.038567342026365,"['TGIF2', 'FGF8', 'NODAL', 'GLI3']",0.40868057048209716,0,0,4
89,Vitamin D Metabolism WP1531,0.0626033920359839,3.622807602534178,10.038567342026365,"['CYP27A1', 'CYP24A1', 'VDR', 'GC']",0.40868057048209716,0,0,4
90,Adipogenesis WP236,0.06632666308873061,1.4410460151802658,3.9097931683867713,"['CEBPA', 'CDKN1A', 'CEBPB', 'CEBPD', 'EPAS1', 'UCP1', 'LPL', 'GATA2', 'FOXO1', 'SOCS3', 'CYP26B1', 'NDN', 'GDF10', 'WWTR1', 'EGR2', 'GADD45B', 'EBF1', 'HMGA1', 'LIFR', 'PRLR', 'KLF15', 'AGT', 'SFRP4', 'LEP', 'ID3', 'PLIN2', 'LPIN3']",0.4253423398715483,0,0,27
91,Differentiation Pathway WP2848,0.06903996662151902,1.8462690631808278,4.93520591977247,"['CSF1R', 'TPO', 'NOTCH1', 'FGF8', 'CSF1', 'HGF', 'FST', 'FGF2', 'DKK1', 'NODAL', 'FGF10']",0.4253423398715483,0,0,11
92,Vitamin B12 metabolism WP1533,0.06903996662151902,1.8462690631808278,4.93520591977247,"['SERPINA3', 'F7', 'TCN2', 'TCN1', 'ALB', 'CCL2', 'SAA2', 'PLG', 'LRP2', 'APOE', 'SOD3']",0.4253423398715483,0,0,11
93,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.06939513581787041,2.8306370913942627,7.551965684165996,"['RYR1', 'CCKBR', 'CD38', 'CCK', 'RYR3']",0.4253423398715483,0,0,5
94,VEGFA-VEGFR2 Signaling Pathway WP3888,0.06954508865027063,1.209747549112143,3.2249207963163764,"['FLT1', 'NCF1', 'ITGB5', 'ARPC5L', 'HSPB1', 'SHB', 'RPL10A', 'ELK1', 'HERPUD1', 'ACTG1', 'RND1', 'TUBB8', 'TUBA1C', 'CDH5', 'GJA1', 'RPS6KA5', 'RPL18A', 'CHAC1', 'ATP6V1E1', 'IER5', 'TMSB10', 'ADAMTS9', 'CLIC1', 'HRAS', 'CGNL1', 'DUSP5', 'HSP90AA1', 'MMP2', 'GAB1', 'CYBB', 'RHOC', 'DKK1', 'EPN1', 'MMP14', 'RCN1', 'TAL1', 'KATNAL2', 'RHOJ', 'TXNIP', 'RPL26', 'ERG', 'ATP6V0D1', 'ALDOA', 'DSC1', 'FJX1', 'ENG', 'ARF6', 'EPHA2', 'KANK1', 'SET', 'PLA2G5', 'FOXO4', 'ADRB2', 'GATA2', 'ACACB', 'FUT1', 'APOLD1', 'FOXO1', 'LDHA', 'PTPRZ1', 'DNAJB4', 'PGK1', 'CCL2', 'DNAJB9', 'IGFBP7', 'ABCF2', 'MAPK3', 'EGR1', 'JUN', 'EGR3', 'TNFRSF10C', 'NFATC2', 'NFATC1', 'BMX', 'SELE', 'QKI', 'RAB11A', 'DNAJA1', 'NFKBIA', 'NR4A1', 'NR4A3', 'ALB', 'CYCS', 'HYOU1', 'PTPN6', 'EIF4G2', 'HSPA1A']",0.4253423398715483,0,0,87
95,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.07006935175307274,2.2650200267022695,6.021034306336803,"['CD86', 'IL4R', 'CD80', 'CCL2', 'TLR7', 'TLR4', 'TGFBR2']",0.4253423398715483,0,0,7
96,Cancer immunotherapy by PD-1 blockade WP4585,0.07101240441917415,2.4706524706524706,6.534630466557028,"['ZAP70', 'JUN', 'CD8B', 'NFATC2', 'NFATC1', 'BATF']",0.4253423398715483,0,0,6
97,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.07101240441917415,2.4706524706524706,6.534630466557028,"['SPP1', 'HSPB1', 'PDLIM5', 'TLR4', 'EGFR', 'ETS2']",0.4253423398715483,0,0,6
98,Prostaglandin Synthesis and Regulation WP98,0.07543254023679176,1.7542951434950012,4.534004795001569,"['HSD11B2', 'HPGDS', 'HPGD', 'ANXA2', 'CYP11A1', 'ANXA3', 'PTGER3', 'TBXAS1', 'S100A6', 'SOX9', 'S100A10', 'PTGDR']",0.4472072028324083,0,0,12
99,FTO Obesity Variant Mechanism WP3407,0.07692841808725559,4.527666666666667,11.61292133923749,"['TBX1', 'PRDM16', 'UCP1']",0.4514687970575303,0,0,3
100,IL-18 signaling pathway WP4754,0.08444575090723429,1.2681923694680346,3.134522536210638,"['SPON1', 'CD83', 'NCF1', 'HSPB1', 'TNFAIP3', 'EPS8', 'PPP1R13L', 'FAM186B', 'TGM2', 'TICAM2', 'USP5', 'MMP2', 'BPGM', 'KRT31', 'ACTA2', 'ARL4D', 'ACTA1', 'MMP14', 'LTB', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'SDC4', 'MEPCE', 'TNFRSF11B', 'GATA1', 'ACACB', 'FUT1', 'SOCS3', 'PTPRZ1', 'SPP1', 'HMOX1', 'CCL2', 'MAPK3', 'SLC12A3', 'JUN', 'NFKBIA', 'NR4A1', 'COL3A1', 'COL1A2', 'TNIP3', 'CYCS', 'PTX3', 'NFKBIE', 'IL18R1', 'CDK5R2', 'SNTB1', 'ITM2C']",0.48329712285671134,0,0,50
101,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.08565900736566874,1.6269741187773974,3.998095116037336,"['CEBPA', 'CDKN1A', 'CEBPB', 'TCF7L1', 'NOTCH1', 'ICMT', 'MSTN', 'CEBPD', 'LEF1', 'TNFRSF11B', 'KAT2B', 'SPP1', 'HES1', 'HES5']",0.48329712285671134,0,0,14
102,"COVID-19, thrombosis and anticoagulation WP4927",0.08642705854106669,9.053648783738753,22.167446876394383,"['F13A1', 'PLG']",0.48329712285671134,0,0,2
103,Eicosanoid Synthesis WP167,0.08734285352832133,2.11386292834891,5.153416153858521,"['PTGES2', 'ALOX5', 'ALOX15', 'ALOX5AP', 'TBXAS1', 'PLA2G5', 'LTC4S']",0.48329712285671134,0,0,7
104,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.08734285352832133,2.11386292834891,5.153416153858521,"['ABCC3', 'JUN', 'ABCC2', 'SRXN1', 'EPHX1', 'HMOX1', 'ABCG2']",0.48329712285671134,0,0,7
105,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.08734285352832133,2.11386292834891,5.153416153858521,"['GSK3A', 'BCL2L10', 'BCL2A1', 'ITGB4', 'ITGA6', 'BCL2L14', 'BCL2L2']",0.48329712285671134,0,0,7
106,BMP Signaling Pathway in Eyelid Development WP3927,0.09082504329698879,2.264597931264598,5.432363317124615,"['FOXC1', 'JUN', 'NOTCH1', 'EGFR', 'MAPK3', 'FGF10']",0.497824058071231,0,0,6
107,Vitamin A and carotenoid metabolism WP716,0.09434640147822912,1.718686612576065,4.057444673028221,"['ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'NPC1L1', 'ALDH1A2', 'ALDH1A1', 'LPL', 'BCO1', 'RPE65']",0.5122921426060852,0,0,11
108,Cardiac Progenitor Differentiation WP2406,0.10191547882918599,1.742527435811766,3.9792556011150526,"['MESP1', 'PDGFRA', 'NOTCH1', 'ACTC1', 'CXCR4', 'PAX6', 'THY1', 'FGF2', 'DKK1', 'NODAL']",0.5482675296273802,0,0,10
109,Osteoblast differentiation WP4787,0.10945163128665812,1.3657383058088635,3.021385365412731,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'WNT8A', 'LRP5', 'FGF2', 'PIK3R6', 'GLI3', 'PIK3R5', 'GLI2', 'FGF8', 'HEY1', 'HEY2', 'SOX9', 'MAPK3', 'WNT10A', 'PRKCH', 'FZD2', 'PTCH1', 'FZD9', 'WNT9A', 'WNT16', 'BMPR1B', 'FGFR4', 'FGF10']",0.556508341865388,0,0,25
110,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.11273997916007601,1.2133382363296379,2.6483184014582224,"['CDKN1A', 'CHRM1', 'CSF3R', 'FLT1', 'CSF1', 'ITGB5', 'ITGB4', 'ITGB2', 'TNC', 'SLC2A3', 'HIF3A', 'FGF2', 'GYS2', 'FGF8', 'CREB3L1', 'ITGAX', 'TNR', 'ITGB8', 'HRAS', 'PDGFRA', 'HSP90AA1', 'IL4R', 'VWF', 'HGF', 'OSMR', 'PRLR', 'COL4A6', 'ITGA8', 'ITGA6', 'EPHA2', 'PFKFB1', 'CSF1R', 'PHLPP1', 'EPAS1', 'LPAR1', 'LPAR3', 'THBS1', 'EGFR', 'FOXO1', 'THBS4', 'PIK3R5', 'GNG3', 'RELN', 'SPP1', 'MAPK3', 'NGFR', 'ANGPT2', 'LAMB3', 'LAMB2', 'VEGFC', 'GNG11', 'FGF17', 'COL3A1', 'EFNA3', 'COL1A2', 'ITGA10', 'FGFR4', 'FGF10']",0.556508341865388,0,0,58
111,IL-3 signaling pathway WP286,0.11452667695870991,1.5991503923535313,3.465274939375069,"['CD86', 'LYN', 'HCK', 'JUN', 'SYK', 'YWHAB', 'INPP5D', 'CSF2RB', 'PTPN6', 'HRAS', 'VAV1', 'MAPK3']",0.556508341865388,0,0,12
112,Benzo(a)pyrene metabolism WP696,0.11695101975710663,3.3955,7.286743225430417,"['EPHX1', 'CYP1B1', 'CYP3A4']",0.556508341865388,0,0,3
113,COVID-19 adverse outcome pathway WP4891,0.11695101975710663,3.3955,7.286743225430417,"['IL7', 'CCL2', 'AGT']",0.556508341865388,0,0,3
114,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.11695101975710663,3.3955,7.286743225430417,"['CEBPB', 'ALDH1L1', 'ALDH1A1']",0.556508341865388,0,0,3
115,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.11695101975710663,3.3955,7.286743225430417,"['HEY1', 'VEGFC', 'HES1']",0.556508341865388,0,0,3
116,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.1181027305622825,1.6778656371038596,3.5842573043253765,"['NFKBIA', 'CASP7', 'HSP90AA1', 'CASP5', 'CASP1', 'CARD6', 'ERBIN', 'NLRC4', 'NOD2', 'AAMP']",0.556508341865388,0,0,10
117,Airway smooth muscle cell contraction WP4962,0.11882559606036526,2.264176117411608,4.822918016052678,"['RYR1', 'CD38', 'ADRB2', 'CALM1', 'CALM2']",0.556508341865388,0,0,5
118,Cori Cycle WP1946,0.11882559606036526,2.264176117411608,4.822918016052678,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA']",0.556508341865388,0,0,5
119,Development and heterogeneity of the ILC family WP3893,0.11882559606036526,2.264176117411608,4.822918016052678,"['IL33', 'IL5', 'NFIL3', 'IL15', 'IL7']",0.556508341865388,0,0,5
120,ID signaling pathway WP53,0.11882559606036526,2.264176117411608,4.822918016052678,"['PAX8', 'CDK2', 'ID3', 'ELK1', 'PAX2']",0.556508341865388,0,0,5
121,Major receptors targeted by epinephrine and norepinephrine WP4589,0.11882559606036526,2.264176117411608,4.822918016052678,"['ADCY10', 'ADCY4', 'ADRB1', 'ADRA1D', 'ADRB2']",0.556508341865388,0,0,5
122,Selective expression of chemokine receptors during T-cell polarization WP4494,0.11882559606036526,2.264176117411608,4.822918016052678,"['CCR1', 'IL4R', 'IL5', 'CXCR4', 'IL18R1']",0.556508341865388,0,0,5
123,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.11892849836577518,1.8118196994991653,3.857785969047131,"['GGT5', 'CYSLTR2', 'HPGD', 'TRPA1', 'ALOX5', 'ALOX15', 'CYP4A11', 'LTC4S']",0.556508341865388,0,0,8
124,Pathogenic Escherichia coli infection WP2272,0.11922714599065655,1.5501144164759726,3.296666796317999,"['TUBB', 'ARPC5L', 'LY96', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1C', 'TUBB2A', 'TUBB3', 'HCLS1', 'CD14', 'TLR5', 'TLR4']",0.556508341865388,0,0,13
125,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.12164640175026555,2.58733863668842,5.450582757383193,"['HSD11B2', 'STAR', 'CYP11A1', 'HSD3B1']",0.556508341865388,0,0,4
126,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.12164640175026555,2.58733863668842,5.450582757383193,"['TPO', 'CSF1', 'IRF8', 'IKZF1']",0.556508341865388,0,0,4
127,Glycolysis in senescence WP5049,0.12164640175026555,2.58733863668842,5.450582757383193,"['LDHA', 'PKM', 'PGK1', 'ALDOC']",0.556508341865388,0,0,4
128,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.12829582737631798,1.6986472945891784,3.488030433837655,"['YAP1', 'FYB1', 'LATS2', 'RAB13', 'LPL', 'FOXO4', 'FOXO1', 'TEAD2', 'TEAD3']",0.5778284938421763,0,0,9
129,The influence of laminopathies on Wnt signaling WP4844,0.12829582737631798,1.6986472945891784,3.488030433837655,"['CEBPA', 'CEBPB', 'TCF7L1', 'ICMT', 'CEBPD', 'LEF1', 'SPP1', 'HES1', 'HES5']",0.5778284938421763,0,0,9
130,Exercise-induced Circadian Regulation WP410,0.12974034195403236,1.5533457515403353,3.1722740644110687,"['PER2', 'DNAJA1', 'CLDN5', 'CEBPB', 'TUBB3', 'STBD1', 'SUMO3', 'G0S2', 'GFRA1', 'QKI', 'EIF4G2', 'HERPUD1']",0.5798395282714831,0,0,12
131,Oxidative Damage WP3941,0.13562515097682012,1.6178225383036609,3.2321836506357338,"['C1QB', 'C1QA', 'CDKN1A', 'C1R', 'C5AR1', 'C3AR1', 'CYCS', 'TNFRSF1B', 'NFKBIE', 'C1QC']",0.6015130741796374,0,0,10
132,22q11.2 copy number variation syndrome WP4657,0.1379872064474552,1.336620203063156,2.6473023621682206,"['TBX1', 'RANBP1', 'FOXC1', 'OAT', 'VWF', 'SERPIND1', 'LRRC74B', 'RTN4', 'EGFR', 'SLC7A4', 'ACTA2', 'CLDN5', 'CYP26B1', 'FGF8', 'RELN', 'ACTC1', 'THAP7', 'ALDH1A2', 'RCC1', 'HES1', 'PRODH', 'RAN', 'FGF10']",0.6073527798937233,0,0,23
133,Cell migration and invasion through p75NTR WP4561,0.13952585674395754,1.7254153748310677,3.3982147977144157,"['NGFR', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'BDNF', 'MMP2', 'PARD3']",0.6095076899867619,0,0,8
134,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.14141347137623717,1.5572150735294117,3.0460174200160672,"['ACTA2', 'ACTA1', 'ACTC1', 'ITGB5', 'ITGB4', 'ITGB2', 'ITGB8', 'LIMD1', 'TEAD2', 'ACTG1', 'TEAD3']",0.6131434841014461,0,0,11
135,Canonical and non-canonical Notch signaling WP3845,0.1519107442255376,1.7611630321910696,3.318845055920775,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'MAML2', 'HEY1', 'LEF1', 'HES1']",0.6414651125404236,0,0,7
136,Aflatoxin B1 metabolism WP699,0.15236176511287172,4.5264911696101295,8.51658205609581,"['EPHX1', 'CYP3A4']",0.6414651125404236,0,0,2
137,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.15236176511287172,4.5264911696101295,8.51658205609581,"['CHRM1', 'CCKBR']",0.6414651125404236,0,0,2
138,Vitamin B6-dependent and responsive disorders WP4228,0.15236176511287172,4.5264911696101295,8.51658205609581,"['PNPO', 'AASS']",0.6414651125404236,0,0,2
139,ACE Inhibitor Pathway WP554,0.15750222678266845,2.2637545848616205,4.184133100562108,"['MAS1', 'ATP6AP2', 'REN', 'AGT']",0.6583366457606501,0,0,4
140,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.16176645165505119,1.6468659887691608,2.9999337866387417,"['FKBP10', 'ADAMTS2', 'COL1A2', 'CREB3L1', 'SERPINF1', 'LRP5', 'SERPINH1', 'TNFRSF11B']",0.6633847228319621,0,0,8
141,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.1628454882792453,2.7162,4.929776567428691,"['APOE', 'TLR4', 'TLR2']",0.6633847228319621,0,0,3
142,NAD Biosynthesis II (from tryptophan) WP2485,0.1628454882792453,2.7162,4.929776567428691,"['KYNU', 'HAAO', 'KMO']",0.6633847228319621,0,0,3
143,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.1633026644378864,1.4691642495052726,2.6623459402701974,"['NFKBIA', 'ZAP70', 'JUN', 'IL5', 'PTPRC', 'NFATC2', 'MAP3K8', 'PTPN6', 'CALM1', 'CALM2', 'CARD11', 'MAPK3']",0.6633847228319621,0,0,12
144,IL1 and megakaryocytes in obesity WP2865,0.16556073117148798,1.811277944611278,3.2574334018858426,"['TLR1', 'IL1R1', 'TIMP2', 'CCL2', 'S100A9', 'TLR2']",0.6633847228319621,0,0,6
145,Matrix Metalloproteinases WP129,0.16556073117148798,1.811277944611278,3.2574334018858426,"['MMP14', 'MMP26', 'MMP2', 'TIMP2', 'MMP19', 'MMP21']",0.6633847228319621,0,0,6
146,Mesodermal commitment pathway WP2857,0.16975853339418753,1.256610366919045,2.228445485179715,"['YAP1', 'FOXC1', 'LEF1', 'FGF8', 'ZIC2', 'ZIC3', 'RPL38', 'TEAD2', 'VAV3', 'TBX1', 'TCF7L1', 'PBX3', 'PAX6', 'ZIC5', 'TBX6', 'SMAD6', 'KLF4', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'TBX3', 'ARL4A', 'MEIS1', 'PRKAR1A', 'BHLHE40', 'RGS10', 'NODAL']",0.6755459445344039,0,0,28
147,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.17349001783256998,1.3244947411837493,2.3200316312120783,"['TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'LRP5', 'FZD9', 'WNT16', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'FRAT2', 'SFRP2', 'WIF1', 'NOTUM']",0.6813091534480663,0,0,19
148,Senescence and Autophagy in Cancer WP615,0.17355207351172772,1.303588655218985,2.2829455973064348,"['GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'SERPINB2', 'GSN', 'IGFBP5', 'CDKN2A', 'HMGA1', 'CXCL1', 'CXCL14', 'THBS1', 'MMP14', 'COL3A1', 'MAP1LC3A', 'IFI16', 'IRF7', 'IGFBP7', 'HRAS', 'CD44', 'SLC39A3']",0.6813091534480663,0,0,21
149,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.17729268399263104,1.6683472700442696,2.8861629157269317,"['ABCC3', 'ABCC2', 'CYP24A1', 'VDR', 'CYP4A11', 'CYP3A4', 'ABCB11']",0.6913224791927425,0,0,7
150,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.18053054768184745,1.8865354680898376,3.2294756949652337,"['CDKN1A', 'CYP24A1', 'SPP1', 'ALPL', 'ROS1']",0.6946241602857839,0,0,5
151,miR-509-3p alteration of YAP1/ECM axis WP3967,0.18053054768184745,1.8865354680898376,3.2294756949652337,"['YAP1', 'COL3A1', 'PBX3', 'TEAD2', 'TEAD3']",0.6946241602857839,0,0,5
152,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.18552903050308542,1.5751469841039414,2.653404260231057,"['PDGFRA', 'EDA', 'PTCH1', 'GJB6', 'LEF1', 'LRP5', 'GLI1', 'GLI2']",0.7091603073835041,0,0,8
153,Neural Crest Differentiation WP2064,0.18765475353918898,1.3043301649199772,2.1823418699044486,"['NOTCH2', 'NOTCH3', 'TCF7L1', 'NOTCH1', 'MIA', 'DLX5', 'WNT8A', 'ZIC5', 'TBX6', 'FGF2', 'BMP7', 'GFAP', 'FGF8', 'PAX7', 'HEY2', 'ZIC1', 'HES1', 'SOX9', 'HES5']",0.7125974627860705,0,0,19
154,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.1914103952675572,1.5095747049654866,2.4958334340658856,"['STAR', 'CYP11A1', 'CREB3L1', 'HSD3B1', 'CALM3', 'REN', 'CALM1', 'CALM2', 'AGT']",0.7221392185094204,0,0,9
155,Statin inhibition of cholesterol production WP430,0.1948924394262666,1.697947947947948,2.7766669549487224,"['APOC2', 'APOC1', 'LPL', 'HMGCR', 'APOE', 'ACSS1']",0.7277707446561965,0,0,6
156,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.19666094132706172,2.012078100107443,3.2721905880432267,"['ANXA2', 'LIPG', 'LPL', 'APOE']",0.7277707446561965,0,0,4
157,Osteoclast Signaling WP12,0.19666094132706172,2.012078100107443,3.2721905880432267,"['ATP6V1G1', 'GPR68', 'SPP1', 'TNFRSF11B']",0.7277707446561965,0,0,4
158,Striated Muscle Contraction Pathway WP383,0.20432063084434846,1.5848130841121495,2.51678587214509,"['ACTA2', 'MYOM1', 'ACTA1', 'ACTC1', 'VIM', 'MYL9', 'ACTG1']",0.7513309273453573,0,0,7
159,Melatonin metabolism and effects WP3298,0.21067057599208266,1.5094045631608235,2.3508366524628537,"['PER2', 'CYP1B1', 'ADRB1', 'APOE', 'CYP2C19', 'CALM1', 'CALM2', 'FOXO1']",0.763787424874846,0,0,8
160,Estrogen Receptor Pathway WP2881,0.2129665453179433,2.263333333333333,3.500517029679345,"['JUN', 'PDK4', 'CYP1B1']",0.763787424874846,0,0,3
161,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.2129665453179433,2.263333333333333,3.500517029679345,"['LFNG', 'NOTCH1', 'TBX6']",0.763787424874846,0,0,3
162,Trans-sulfuration pathway WP2333,0.2129665453179433,2.263333333333333,3.500517029679345,"['AHCY', 'GOT1', 'MAT2B']",0.763787424874846,0,0,3
163,Netrin-UNC5B signaling pathway WP4747,0.21969824479336247,1.3837826797385622,2.097123050682963,"['YAP1', 'CDH5', 'ROBO4', 'JUN', 'VCAM1', 'ITGB4', 'INPP5D', 'CCL2', 'ALPL', 'SELE', 'MAPK3']",0.7723346872461948,0,0,11
164,Ebola Virus Pathway on Host WP4217,0.22237483984697526,1.2179820475602448,1.8311030696515478,"['ICAM2', 'EGFR', 'ACTG1', 'SOCS3', 'SCIN', 'HLA-DOA', 'HLA-DQA1', 'HLA-DPA1', 'MAPK3', 'VPS18', 'HLA-DRB5', 'GSN', 'CAV3', 'CD300A', 'RHOC', 'MERTK', 'HLA-E', 'BST2', 'AXL', 'NEDD4', 'IRF7', 'HLA-DRA', 'ITGA6', 'TLR4', 'CLEC4G']",0.7723346872461948,0,0,25
165,miR-517 relationship with ARCN1 and USP1 WP3596,0.22436718147786783,3.0174386315672552,4.509475633925153,"['CDKN1A', 'ARCN1']",0.7723346872461948,0,0,2
166,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.22436718147786783,3.0174386315672552,4.509475633925153,"['EGFR', 'MAPK3']",0.7723346872461948,0,0,2
167,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.225984331896477,1.597950892068539,2.376615759071496,"['BDNF', 'FSHR', 'CGA', 'SGK1', 'FOXO1', 'MAPK3']",0.7723346872461948,0,0,6
168,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.225984331896477,1.597950892068539,2.376615759071496,"['TGFBR3', 'ANGPT2', 'LTBP1', 'MAPK3', 'TGFBR2', 'ENG']",0.7723346872461948,0,0,6
169,RAS and bradykinin pathways in COVID-19 WP4969,0.225984331896477,1.597950892068539,2.376615759071496,"['CYP24A1', 'VDR', 'F12', 'REN', 'CYP3A4', 'AGT']",0.7723346872461948,0,0,6
170,"Relationship between inflammation, COX-2 and EGFR WP4483",0.225984331896477,1.597950892068539,2.376615759071496,"['PTGES2', 'PTGER3', 'HRAS', 'EGFR', 'MAPK3', 'PLA1A']",0.7723346872461948,0,0,6
171,Hedgehog Signaling Pathway Netpath WP47,0.238357088995564,1.8107369123041013,2.596570215479763,"['PTCH1', 'GLI1', 'GLI3', 'GLI2']",0.8046646725588417,0,0,4
172,Small Ligand GPCRs WP247,0.238357088995564,1.8107369123041013,2.596570215479763,"['CNR2', 'PTGER3', 'LPAR1', 'PTGDR']",0.8046646725588417,0,0,4
173,Neural Crest Cell Migration during Development WP4564,0.2395989472507394,1.4052587934489669,2.0078180343559264,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'MMP2', 'PIK3R6', 'EPHB4', 'F2RL2', 'PIK3R5']",0.8046646725588417,0,0,9
174,GDNF/RET signaling axis WP4830,0.2513670226058217,1.6167921471457163,2.2325331543345652,"['FOXC1', 'EYA1', 'GFRA1', 'PAX2', 'GLI3']",0.834538515051328,0,0,5
175,Transcription factor regulation in adipogenesis WP3599,0.2513670226058217,1.6167921471457163,2.2325331543345652,"['CEBPA', 'CEBPB', 'CEBPD', 'LEP', 'FOXO1']",0.834538515051328,0,0,5
176,Regulatory circuits of the STAT3 signaling pathway WP4538,0.25806026606383276,1.2579949427338986,1.7040323116038638,"['PDGFRA', 'DUSP2', 'CSF3R', 'IL10RA', 'LIFR', 'CSF2RB', 'OSMR', 'CSF2RA', 'MAPK15', 'EGFR', 'SOCS3', 'PTPRC', 'IL21R', 'F2RL2', 'MAPK3']",0.8518921283129934,0,0,15
177,Modulators of TCR signaling and T cell activation WP5072,0.26310845709269665,1.2937861202655585,1.7274489281150587,"['NFKBIA', 'ZAP70', 'CD5', 'TNFAIP3', 'RHOH', 'ELOB', 'MAP3K8', 'PTPN6', 'CD247', 'VAV1', 'CARD11', 'ZFP36L1']",0.8625669969274169,0,0,12
178,IL-5 signaling pathway WP127,0.2651485736937213,1.358316633266533,1.8031177279882682,"['LYN', 'GSK3A', 'SPRED1', 'JUN', 'SYK', 'BTK', 'CSF2RB', 'ELK1', 'MAPK3']",0.8625669969274169,0,0,9
179,Neuroinflammation WP4919,0.2657478355421818,1.939857142857143,2.5707130532808056,"['NFKBIA', 'JUN', 'TLR4']",0.8625669969274169,0,0,3
180,Wnt signaling WP428,0.2735040786913638,1.1862590054471973,1.5379121354163463,"['WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'FZD9', 'LRP5', 'NFATC2', 'NFATC1', 'WNT16', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'FRAT2', 'SFRP2', 'DAAM2', 'WIF1', 'NOTUM']",0.8828103873315687,0,0,22
181,Prader-Willi and Angelman Syndrome WP3998,0.2852380244045293,1.2636047677917472,1.5851053386018168,"['PCSK1', 'GABRR2', 'MAGEL2', 'DLX5', 'CDKN2A', 'BDNF', 'NDN', 'MKRN3', 'ATP10A', 'CGA', 'TYR', 'GABRD']",0.9067449767640738,0,0,12
182,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.2890635352312307,1.5088948187680675,1.8727025924920853,"['BCL6', 'H2AFZ', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.9067449767640738,0,0,5
183,One-carbon metabolism WP241,0.2890635352312307,1.5088948187680675,1.8727025924920853,"['ALDH1L1', 'AHCY', 'FOLH1', 'TCN2', 'MAT2B']",0.9067449767640738,0,0,5
184,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.2890635352312307,1.5088948187680675,1.8727025924920853,"['GSDMD', 'NFKBIA', 'FCGR2A', 'CGAS', 'NFKBIE']",0.9067449767640738,0,0,5
185,Nephrotic syndrome WP4758,0.2914767673192441,1.314402999547482,1.6203894153545468,"['ANLN', 'ITGB4', 'LAMB2', 'ARHGDIA', 'COL4A5', 'GPC5', 'EMP2', 'ARHGAP24', 'PAX2']",0.9067449767640738,0,0,9
186,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.29270109463938165,1.3413961540839672,1.6480438025370712,"['LDHA', 'ANGPT2', 'PKM', 'BCL2A1', 'IGFBP2', 'PGK1', 'PMAIP1', 'SLC2A3']",0.9067449767640738,0,0,8
187,GABA receptor Signaling WP4159,0.29310316633239447,1.3777935798455911,1.6908704808206605,"['GABRQ', 'GABRA1', 'SLC32A1', 'GAD1', 'GABRE', 'GABRD', 'AP2M1']",0.9067449767640738,0,0,7
188,Apoptosis WP254,0.2936106295560183,1.2075438009150765,1.4798458683204019,"['JUN', 'CRADD', 'CDKN2A', 'TNFRSF1B', 'NFKBIA', 'CASP7', 'CASP6', 'CASP10', 'CASP4', 'CASP1', 'TNFSF10', 'IRF7', 'PMAIP1', 'CYCS', 'NFKBIE', 'BCL2L2']",0.9067449767640738,0,0,16
189,Composition of Lipid Particles WP3601,0.2980865586263995,2.262912362545818,2.738964335232318,"['LPL', 'APOE']",0.9067449767640738,0,0,2
190,let-7 inhibition of ES cell reprogramming WP3299,0.2980865586263995,2.262912362545818,2.738964335232318,"['EGR1', 'KLF4']",0.9067449767640738,0,0,2
191,Metabolism of alpha-linolenic acid WP4586,0.2980865586263995,2.262912362545818,2.738964335232318,"['ALOX5', 'ALOX15']",0.9067449767640738,0,0,2
192,Cytoplasmic Ribosomal Proteins WP477,0.3047136129991084,1.181297793314398,1.4038341177719589,"['RPL41', 'RPL3', 'RPS7', 'RPSA', 'RPL10A', 'RPS4Y1', 'RPS15', 'RPS26', 'RPL7A', 'RPS25', 'RPL18A', 'RPL14', 'RPL38', 'RPL26', 'RPL15', 'FAU', 'RPL18', 'RPL17']",0.9108583168196583,0,0,18
193,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.31148214473252483,1.2450367647058824,1.4522273948750462,"['VAV3', 'BEX3', 'SOCS3', 'CDKN1A', 'CASP7', 'ERBB3', 'HSPB1', 'APOE', 'VIM', 'YBX3', 'THBS1']",0.9108583168196583,0,0,11
194,Focal Adhesion WP306,0.3137215904066954,1.1099190382837725,1.2866729138497197,"['SHC4', 'SHC3', 'FLT1', 'ITGB5', 'ITGB4', 'TNC', 'ELK1', 'THBS1', 'EGFR', 'THBS4', 'ACTG1', 'RELN', 'SPP1', 'TNR', 'ITGB8', 'HRAS', 'MAPK3', 'VAV3', 'PDGFRA', 'JUN', 'CAV3', 'VWF', 'LAMB3', 'LAMB2', 'HGF', 'VEGFC', 'VAV1', 'FGR', 'HCK', 'COL1A2', 'PARVG', 'ITGA10', 'COL4A6', 'ITGA8', 'ITGA6', 'MYL9', 'DOCK1']",0.9108583168196583,0,0,37
195,Neural Crest Cell Migration in Cancer WP4565,0.3184329796955809,1.2732339679358717,1.4570166980622001,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'MMP2', 'PIK3R6', 'EPHB4', 'F2RL2', 'PIK3R5']",0.9108583168196583,0,0,9
196,Pathways Regulating Hippo Signaling WP4540,0.318467559452106,1.162633142525904,1.3303251423922435,"['NTRK1', 'PDGFRA', 'CSF1R', 'NGFR', 'TCF7L1', 'PRKCH', 'FLT1', 'LEF1', 'EGFR', 'CDH5', 'LATS2', 'PRKAR1A', 'CDH20', 'FGFR4', 'CDH17', 'TEAD2', 'EPHA2', 'TEAD3', 'CDH19']",0.9108583168196583,0,0,19
197,Alanine and aspartate metabolism WP106,0.3197858658953311,1.69725,1.9350409645306115,"['GOT1', 'GAD1', 'ASPA']",0.9108583168196583,0,0,3
198,Biogenic Amine Synthesis WP550,0.3197858658953311,1.69725,1.9350409645306115,"['TPH1', 'GAD1', 'PAH']",0.9108583168196583,0,0,3
199,Osteoblast Signaling WP322,0.3197858658953311,1.69725,1.9350409645306115,"['PDGFRA', 'TNFRSF11B', 'PTH1R']",0.9108583168196583,0,0,3
200,Aryl Hydrocarbon Receptor Pathway WP2873,0.3244789510769675,1.3202881619937694,1.4860300223584813,"['HSP90AA1', 'JUN', 'SERPINB2', 'MYOF', 'CYP1B1', 'HES1', 'EGFR']",0.9108583168196583,0,0,7
201,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.32630093162689305,1.2011535048802129,1.3452141150578718,"['CDKN1A', 'JUN', 'FZD2', 'FZD9', 'WNT16', 'ELK1', 'EGFR', 'ACTA1', 'NEFL', 'PFN4', 'NEFM', 'NEFH', 'PFN2']",0.9108583168196583,0,0,13
202,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.32630093162689305,1.2011535048802129,1.3452141150578718,"['JUN', 'PRKCH', 'VDR', 'NOD2', 'IFI44L', 'CYP24A1', 'OAS2', 'PLCG2', 'CCL2', 'HRAS', 'TLR4', 'TLR2', 'MAPK3']",0.9108583168196583,0,0,13
203,FOXA2 pathway WP5066,0.3263243301740578,1.5087251305990885,1.689566226931589,"['ABCC3', 'SLCO1B1', 'ABCC2', 'FOXO1']",0.9108583168196583,0,0,4
204,Serotonin and anxiety WP3947,0.3263243301740578,1.5087251305990885,1.689566226931589,"['GABRA1', 'ARC', 'PLEK', 'CRH']",0.9108583168196583,0,0,4
205,7-oxo-C and 7beta-HC pathways WP5064,0.32666344497627176,1.357957957957958,1.5193171199600084,"['CYP27A1', 'HSD11B2', 'ACOT11', 'THEM5', 'ACOT6', 'ACOT4']",0.9108583168196583,0,0,6
206,Cannabinoid receptor signaling WP3869,0.32666344497627176,1.357957957957958,1.5193171199600084,"['CNR2', 'ADORA2A', 'PRKAR1A', 'CYP2C19', 'CYP3A4', 'MAPK3']",0.9108583168196583,0,0,6
207,Ethanol effects on histone modifications WP3996,0.32666344497627176,1.357957957957958,1.5193171199600084,"['KAT2B', 'ALDH1A3', 'AHCY', 'ADH1B', 'ALDH1A2', 'ALDH1A1']",0.9108583168196583,0,0,6
208,Globo Sphingolipid Metabolism WP1424,0.3276581552759184,1.414484656437625,1.5782599470751817,"['ST6GAL1', 'FUT2', 'A4GALT', 'FUT1', 'ABO']",0.9108583168196583,0,0,5
209,miRNA targets in ECM and membrane receptors WP2911,0.3276581552759184,1.414484656437625,1.5782599470751817,"['COL3A1', 'COL1A2', 'ITGB5', 'LAMB2', 'THBS1']",0.9108583168196583,0,0,5
210,Metabolic reprogramming in colon cancer WP4290,0.34586455673939004,1.2345600291492076,1.3107423027278733,"['ACLY', 'LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'SUCLG2', 'SLC1A5', 'ALDOB']",0.9322940412918588,0,0,9
211,AGE/RAGE pathway WP2324,0.3486521396277535,1.1770434782608696,1.2402278647944627,"['JUN', 'NCF1', 'MMP2', 'MSN', 'FOXO4', 'FOXO1', 'EGFR', 'NFKBIA', 'LGALS3', 'MMP14', 'ALPL', 'CYCS', 'MAPK3']",0.9322940412918588,0,0,13
212,Bladder cancer WP2828,0.351066861084297,1.2487018594208739,1.3071143670361534,"['CDKN1A', 'RPS6KA5', 'CDKN2A', 'DAPK2', 'MMP2', 'THBS1', 'HRAS', 'EGFR']",0.9322940412918588,0,0,8
213,Alpha 6 Beta 4 signaling pathway WP244,0.3563452894425387,1.2673831775700934,1.3077558005355503,"['LAMB3', 'ITGB4', 'LAMB2', 'GAB1', 'ITGA6', 'HRAS', 'MAPK3']",0.9322940412918588,0,0,7
214,Acute viral myocarditis WP4298,0.35860364755959373,1.150959771288544,1.1803524596179913,"['ENDOG', 'CD80', 'ITGB2', 'CXCR4', 'NOD2', 'AIF1', 'CASP7', 'CASP6', 'CASP1', 'CYCS', 'TLR5', 'TLR4', 'TLR3', 'EIF4G2', 'MAPK3']",0.9322940412918588,0,0,15
215,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.36161852700376196,1.2931979598646266,1.3153962402905943,"['TGFBR3', 'HGF', 'HRAS', 'EGFR', 'PIK3R5', 'TGFBR2']",0.9322940412918588,0,0,6
216,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.36161852700376196,1.2931979598646266,1.3153962402905943,"['EGLN2', 'VCAM1', 'BCL2A1', 'MMP2', 'SELE', 'BCL2L2']",0.9322940412918588,0,0,6
217,"GPCRs, Class B Secretin-like WP334",0.3667068861204538,1.331181572028411,1.335431269970584,"['ADGRE1', 'ADGRE2', 'ADGRG2', 'GIPR', 'PTH1R']",0.9322940412918588,0,0,5
218,LDLRAD4 and what we know about it WP4904,0.3705407562959638,1.8101966011329558,1.7971484086043898,"['NEDD4', 'TGFBR2']",0.9322940412918588,0,0,2
219,Mevalonate pathway WP3963,0.3705407562959638,1.8101966011329558,1.7971484086043898,"['HMGCS1', 'HMGCR']",0.9322940412918588,0,0,2
220,Nanomaterial-induced inflammasome activation WP3890,0.3705407562959638,1.8101966011329558,1.7971484086043898,"['CASP1', 'TLR4']",0.9322940412918588,0,0,2
221,Peroxiredoxin 2 induced ovarian failure WP4873,0.3705407562959638,1.8101966011329558,1.7971484086043898,"['STAR', 'CYP11A1']",0.9322940412918588,0,0,2
222,"Phase I biotransformations, non P450 WP136",0.3705407562959638,1.8101966011329558,1.7971484086043898,"['PON3', 'PON2']",0.9322940412918588,0,0,2
223,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.3705407562959638,1.8101966011329558,1.7971484086043898,"['NFKBIA', 'MUC1']",0.9322940412918588,0,0,2
224,SARS-CoV-2 and COVID-19 Pathway WP4846,0.3705407562959638,1.8101966011329558,1.7971484086043898,"['NRP1', 'TLR7']",0.9322940412918588,0,0,2
225,The alternative pathway of fetal androgen synthesis WP4524,0.3705407562959638,1.8101966011329558,1.7971484086043898,"['STAR', 'CYP11A1']",0.9322940412918588,0,0,2
226,15q13.3 copy number variation syndrome WP4942,0.3711839445948795,1.3925667530202375,1.380113768994209,"['TRPM1', 'KAT2B', 'SERPINH1', 'CHRFAM7A']",0.9322940412918588,0,0,4
227,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.3738803986592136,1.5085555555555556,1.4841461044580722,"['SST', 'DKK1', 'FOXO1']",0.9322940412918588,0,0,3
228,Cancer immunotherapy by CTLA4 blockade WP4582,0.3738803986592136,1.5085555555555556,1.4841461044580722,"['CD86', 'CD80', 'PTPN6']",0.9322940412918588,0,0,3
229,Genes targeted by miRNAs in adipocytes WP1992,0.3738803986592136,1.5085555555555556,1.4841461044580722,"['KCNE1', 'GJA1', 'ERG']",0.9322940412918588,0,0,3
230,LTF danger signal response pathway WP4478,0.3738803986592136,1.5085555555555556,1.4841461044580722,"['CD14', 'TLR4', 'TLR2']",0.9322940412918588,0,0,3
231,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.3738803986592136,1.5085555555555556,1.4841461044580722,"['JUN', 'RYR3', 'MAPK3']",0.9322940412918588,0,0,3
232,Serotonin and anxiety-related events WP3944,0.3738803986592136,1.5085555555555556,1.4841461044580722,"['ARC', 'PLEK', 'CRH']",0.9322940412918588,0,0,3
233,Sulfation Biotransformation Reaction WP692,0.3738803986592136,1.5085555555555556,1.4841461044580722,"['SULT1C2', 'SULT1B1', 'SULT4A1']",0.9322940412918588,0,0,3
234,Oncostatin M Signaling Pathway WP2374,0.37812493298853617,1.1557224866087625,1.123975515022072,"['NFKBIA', 'SOCS3', 'EGR1', 'CASP7', 'CEBPB', 'PRKCH', 'CDK2', 'CCL2', 'LIFR', 'OSMR', 'HRAS', 'MAPK3']",0.9388486584031603,0,0,12
235,Ferroptosis WP4313,0.3807916308189479,1.206989426822482,1.165351857282691,"['PRNP', 'MAP1LC3A', 'GPX4', 'ALOX15', 'HMOX1', 'CYBB', 'SLC7A11', 'CP']",0.9392007534172451,0,0,8
236,Chemokine signaling pathway WP3929,0.38149978968411336,1.0899239851204916,1.0502997763465016,"['SHC4', 'CX3CR1', 'SHC3', 'NCF1', 'CXCR5', 'ADCY4', 'CXCR4', 'PRKX', 'CXCL13', 'CXCL14', 'CXCL5', 'CX3CL1', 'PIK3R5', 'PREX1', 'GNG3', 'HRAS', 'MAPK3', 'LYN', 'CCR1', 'VAV3', 'GNG11', 'VAV1', 'NFKBIA', 'FGR', 'HCK', 'PARD3']",0.9392007534172451,0,0,26
237,CAMKK2  Pathway WP4874,0.3884684946950042,1.2185478073328542,1.1521896018707487,"['MAP1LC3A', 'VCAM1', 'HMOX1', 'NFATC2', 'CALM1', 'CALM2', 'MAPK3']",0.9483201488142751,0,0,7
238,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.3884684946950042,1.2185478073328542,1.1521896018707487,"['IFIH1', 'NFKBIA', 'JUN', 'OAS1', 'OAS2', 'OAS3', 'TLR7']",0.9483201488142751,0,0,7
239,Synaptic Vesicle Pathway WP2267,0.3931812068841271,1.1605712474406094,1.0833754878455075,"['NSF', 'RAB3A', 'SLC32A1', 'SLC1A3', 'SLC17A6', 'ATP1A2', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1']",0.9558087079484429,0,0,10
240,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.39675502204514734,1.2343252343252342,1.1410550053378268,"['CEBPA', 'CEBPB', 'ERBB3', 'PGR', 'PRLR', 'EGFR']",0.9604777825342942,0,0,6
241,Notch Signaling WP268,0.40154784103736274,1.1638419696535929,1.0619226954245067,"['NOTCH2', 'LFNG', 'NOTCH3', 'KAT2B', 'NOTCH1', 'DTX3L', 'MFNG', 'HES1', 'HES5']",0.9680468698867541,0,0,9
242,Zinc homeostasis WP3529,0.4057964727422193,1.2571343858868875,1.133813957585112,"['SLC30A3', 'SLC30A2', 'SLC39A11', 'SLC39A12', 'SLC39A3']",0.9690255815023895,0,0,5
243,Corticotropin-releasing hormone signaling pathway WP2355,0.4138097571257301,1.0972801331020279,0.9681839564235355,"['GNAZ', 'HSP90AA1', 'HSD3B1', 'ELK1', 'TBX19', 'FOSL2', 'NFKBIA', 'NR4A1', 'GJA1', 'STAR', 'CYP11A1', 'CRH', 'PLCG2', 'FOSB', 'TLR4', 'MAPK3']",0.9690255815023895,0,0,16
244,Apoptosis Modulation by HSP70 WP384,0.4157985804334881,1.2930024293812223,1.1346798646030123,"['CASP7', 'CASP6', 'CYCS', 'HSPA1A']",0.9690255815023895,0,0,4
245,Nanomaterial induced apoptosis WP2507,0.4157985804334881,1.2930024293812223,1.1346798646030123,"['CASP7', 'ENDOG', 'CASP6', 'CYCS']",0.9690255815023895,0,0,4
246,Nucleotide metabolism WP404,0.4157985804334881,1.2930024293812223,1.1346798646030123,"['PRPS1', 'RRM2', 'POLD1', 'OAZ1']",0.9690255815023895,0,0,4
247,Proteoglycan biosynthesis WP4784,0.4157985804334881,1.2930024293812223,1.1346798646030123,"['XYLT1', 'CHST14', 'B4GALT7', 'CHST3']",0.9690255815023895,0,0,4
248,TP53 network WP1742,0.4157985804334881,1.2930024293812223,1.1346798646030123,"['CDKN1A', 'CDKN2A', 'TNFSF10', 'PMAIP1']",0.9690255815023895,0,0,4
249,Transcription co-factors SKI and SKIL protein partners WP4533,0.4157985804334881,1.2930024293812223,1.1346798646030123,"['LATS2', 'MERTK', 'TEAD2', 'TEAD3']",0.9690255815023895,0,0,4
250,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.41696453593046023,1.1101722723543888,0.9711277541980096,"['CDKN1A', 'CR1', 'KIRREL2', 'NOTCH1', 'ITGB4', 'LAMB2', 'CD80', 'LRP5', 'DKK1', 'PAX2', 'COL4A5', 'VIM', 'TLR4']",0.9690255815023895,0,0,13
251,IL-4 signaling pathway WP395,0.41957686611313105,1.1314734380220515,0.9826943405040429,"['NFKBIA', 'CEBPA', 'SOCS3', 'CEBPB', 'IL4R', 'NFIL3', 'INPP5D', 'PTPN6', 'ELK1', 'MAPK3']",0.9690430250083829,0,0,10
252,Signaling of Hepatocyte Growth Factor Receptor WP313,0.42062533184619544,1.1733298719280028,1.0161186755650886,"['JUN', 'HGF', 'GAB1', 'ELK1', 'HRAS', 'DOCK1', 'MAPK3']",0.9690430250083829,0,0,7
253,T-cell receptor (TCR) signaling pathway WP69,0.42197570624289304,1.0950252623396812,0.9447960470861236,"['VAV3', 'JUN', 'CD83', 'FYB1', 'NFATC2', 'NFATC1', 'VAV1', 'NFKBIA', 'ZAP70', 'MAP3K8', 'CD247', 'VIM', 'HRAS', 'CARD11', 'MAPK3']",0.9690430250083829,0,0,15
254,Cysteine and methionine catabolism WP4504,0.42704621695459216,1.3576,1.1551316565644894,"['AHCY', 'GOT1', 'SQOR']",0.9692676381619175,0,0,3
255,Ganglio Sphingolipid Metabolism WP1423,0.42704621695459216,1.3576,1.1551316565644894,"['B3GALT1', 'B4GALNT1', 'FUT1']",0.9692676381619175,0,0,3
256,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.4295056338774376,1.1314295257181028,0.956194196372007,"['PDGFRA', 'CDKN1A', 'HSP90AA1', 'JUN', 'CDKN2A', 'MMP2', 'TNFSF10', 'ELK1', 'EGFR']",0.9692676381619175,0,0,9
257,Canonical NF-KB pathway WP4562,0.43977248510265937,1.5083860935243807,1.2391358047586782,"['NFKBIA', 'NFKBIE']",0.9692676381619175,0,0,2
258,Dual hijack model of Vif in HIV infection WP3300,0.43977248510265937,1.5083860935243807,1.2391358047586782,"['ELOB', 'RUNX1']",0.9692676381619175,0,0,2
259,HIF1A and PPARG regulation of glycolysis WP2456,0.43977248510265937,1.5083860935243807,1.2391358047586782,"['LDHA', 'TPI1']",0.9692676381619175,0,0,2
260,ESC Pluripotency Pathways WP3931,0.4397846485534243,1.064936601526296,0.8748135839913933,"['PDGFRA', 'WNT10A', 'JUN', 'FZD2', 'FZD9', 'GAB1', 'LRP5', 'LIFR', 'SMAD6', 'WNT16', 'FGF2', 'ELK1', 'EGFR', 'FGF17', 'FGF8', 'SELENOP', 'BMPR1B', 'FGFR4', 'HRAS', 'FGF10']",0.9692676381619175,0,0,20
261,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4398885810815006,1.0895330112721417,0.8947613448253298,"['YAP1', 'ANGPT2', 'MMP2', 'TIE1', 'FOXO1', 'EGFR', 'NFKBIA', 'CASP7', 'RAD51', 'TNIP3', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9692676381619175,0,0,13
262,ATM Signaling Pathway WP2516,0.4404245378222827,1.1313856427378965,0.9277545086076074,"['NFKBIA', 'CDKN1A', 'JUN', 'RAD51', 'CRADD', 'CHEK2', 'CDK2', 'RAD9A']",0.9692676381619175,0,0,8
263,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4404245378222827,1.1313856427378965,0.9277545086076074,"['ACTA1', 'CASP7', 'JUN', 'CASP6', 'CASP10', 'HSPB1', 'CYCS', 'ACTG1']",0.9692676381619175,0,0,8
264,Glycogen Synthesis and Degradation WP500,0.4404245378222827,1.1313856427378965,0.9277545086076074,"['GYS2', 'GSK3A', 'HKDC1', 'PHKA1', 'CALM3', 'CALM1', 'CALM2', 'HK2']",0.9692676381619175,0,0,8
265,Physiological and pathological hypertrophy of the heart WP1528,0.4445519857434571,1.19088164039184,0.9654337858307401,"['JUN', 'LIFR', 'CALM1', 'CALM2', 'AGT']",0.9709951267554457,0,0,5
266,TLR4 Signaling and Tolerance WP3851,0.4445519857434571,1.19088164039184,0.9654337858307401,"['NFKBIA', 'INPP5D', 'IRF7', 'IRAK3', 'TLR4']",0.9709951267554457,0,0,5
267,Nicotine Metabolism WP1600,0.45071563298945283,2.262491672218521,1.8030218404335816,['CYP2A6'],0.9807707219733038,0,0,1
268,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.45964697805767807,1.2067133488940758,0.9379740905172947,"['HTR2B', 'ELK1', 'HRAS', 'MAPK3']",0.992769123611565,0,0,4
269,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.45964697805767807,1.2067133488940758,0.9379740905172947,"['EGR1', 'RPS6KA5', 'ELK1', 'MAPK3']",0.992769123611565,0,0,4
270,Aryl Hydrocarbon Receptor Netpath WP2586,0.4699982375957175,1.0970202863358123,0.8282792052050659,"['CDKN1A', 'HPGDS', 'HSP90AA1', 'CDK2', 'LPL', 'CYP1B1', 'HRAS', 'EGFR']",0.9999958129031761,0,0,8
271,Development of ureteric collection system WP5053,0.4699982375957175,1.0970202863358123,0.8282792052050659,"['FOXC1', 'ITGA8', 'GFRA1', 'GLI1', 'ETV4', 'GLI3', 'PAX2', 'GLI2']",0.9999958129031761,0,0,8
272,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4785068648709117,1.2340909090909091,0.9096295540877073,"['TERT', 'ALPL', 'ITGA6']",0.9999958129031761,0,0,3
273,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.4785068648709117,1.2340909090909091,0.9096295540877073,"['IFIH1', 'OAS1', 'CGAS']",0.9999958129031761,0,0,3
274,Phytochemical activity on NRF2 transcriptional activation WP3,0.4785068648709117,1.2340909090909091,0.9096295540877073,"['CEBPB', 'HMOX1', 'SLC7A11']",0.9999958129031761,0,0,3
275,Oxysterols derived from cholesterol WP4545,0.4842186293953914,1.0922494360296486,0.7921197822968401,"['CYP39A1', 'CYP27A1', 'ACOT11', 'THEM5', 'CYP3A4', 'ACOT6', 'ACOT4']",0.9999958129031761,0,0,7
276,Hepatitis C and Hepatocellular Carcinoma WP3646,0.4992061499920904,1.0646764214867916,0.7396691898690746,"['CDKN1A', 'CASP7', 'JUN', 'RRM2', 'MYOF', 'LEF1', 'CD44', 'MAPK3']",0.9999958129031761,0,0,8
277,Fluoropyrimidine Activity WP1601,0.5005360386134183,1.085965965965966,0.7515706317437175,"['ABCC3', 'CDA', 'CYP2A6', 'RRM2', 'UPB1', 'ABCG2']",0.9999958129031761,0,0,6
278,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.5045741482515109,1.2928071595182558,0.8843324250945809,"['CYP4A11', 'CYP2C18']",0.9999958129031761,0,0,2
279,Estrogen metabolism WP697,0.5045741482515109,1.2928071595182558,0.8843324250945809,"['CYP1B1', 'CYP3A4']",0.9999958129031761,0,0,2
280,FOXP3 in COVID-19 WP5063,0.5045741482515109,1.2928071595182558,0.8843324250945809,"['CD86', 'CD80']",0.9999958129031761,0,0,2
281,Leptin and adiponectin WP3934,0.5045741482515109,1.2928071595182558,0.8843324250945809,"['LEP', 'LEPR']",0.9999958129031761,0,0,2
282,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5045741482515109,1.2928071595182558,0.8843324250945809,"['AHCY', 'MAT2B']",0.9999958129031761,0,0,2
283,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5045741482515109,1.2928071595182558,0.8843324250945809,"['NFKBIA', 'THBD']",0.9999958129031761,0,0,2
284,Vitamin B12 Disorders WP4271,0.5045741482515109,1.2928071595182558,0.8843324250945809,"['TCN2', 'TCN1']",0.9999958129031761,0,0,2
285,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.508058837279132,1.031960335621663,0.6988002141772894,"['TCF7L1', 'ITGB5', 'ITGB4', 'LEF1', 'ATP2A2', 'ACTG1', 'GJA1', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGA6', 'CACNG1', 'CACNG5']",0.9999958129031761,0,0,13
286,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.5152873608414072,1.0557632398753893,0.7000032834163352,"['GABRQ', 'NGFR', 'GABRA1', 'SLC12A5', 'BDNF', 'GABRE', 'GABRD']",0.9999958129031761,0,0,7
287,Vitamin D-sensitive calcium signaling in depression WP4698,0.5152873608414072,1.0557632398753893,0.7000032834163352,"['CYP27A1', 'TPH1', 'CHRM1', 'CALB1', 'GPX4', 'VDR', 'PVALB']",0.9999958129031761,0,0,7
288,Gastric Cancer Network 2 WP2363,0.5197792958814893,1.0773055052574732,0.7049359222818592,"['PLAC8', 'S100A6', 'COL9A1', 'CACYBP', 'EGFR']",0.9999958129031761,0,0,5
289,Galanin receptor pathway WP4970,0.5276777830598355,1.1311666666666667,0.7231202825831324,"['YAP1', 'CDKN1A', 'UCP1']",0.9999958129031761,0,0,3
290,Leptin Insulin Overlap WP3935,0.5276777830598355,1.1311666666666667,0.7231202825831324,"['SOCS3', 'LEP', 'LEPR']",0.9999958129031761,0,0,3
291,Mitochondrial complex III assembly WP4921,0.5276777830598355,1.1311666666666667,0.7231202825831324,"['UQCC3', 'UQCRFS1', 'UQCRH']",0.9999958129031761,0,0,3
292,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5276777830598355,1.1311666666666667,0.7231202825831324,"['PTTG1', 'BUB1B', 'MAD2L1']",0.9999958129031761,0,0,3
293,Tryptophan catabolism leading to NAD+ production WP4210,0.5276777830598355,1.1311666666666667,0.7231202825831324,"['HAAO', 'KYNU', 'KMO']",0.9999958129031761,0,0,3
294,Mitochondrial CIV Assembly WP4922,0.5338108098601283,1.0441210441210442,0.6554091793363236,"['COA3', 'NDUFA4', 'SCO2', 'COX14', 'HIGD1A', 'COX7C']",0.9999958129031761,0,0,6
295,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5390009756112653,1.0179859719438877,0.6291539103296475,"['NFKBIA', 'RPS6KA5', 'IL1R1', 'TOLLIP', 'MKNK2', 'IRF7', 'MAP3K8', 'ELK1', 'MAPK3']",0.9999958129031761,0,0,9
296,Urea cycle and metabolism of amino groups WP497,0.5433833038737353,1.0645901575034815,0.6493364483045468,"['OAT', 'CKM', 'ODC1', 'PYCR3']",0.9999958129031761,0,0,4
297,IL-2 signaling pathway WP49,0.545657348572759,1.0216309918601145,0.6188673445576877,"['SOCS3', 'JUN', 'SYK', 'CISH', 'NMI', 'HRAS', 'MAPK3']",0.9999958129031761,0,0,7
298,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.545657348572759,1.0216309918601145,0.6188673445576877,"['PRKCH', 'STAR', 'CYP11A1', 'FSHR', 'HSD3B1', 'HRAS', 'MAPK3']",0.9999958129031761,0,0,7
299,Pathways in clear cell renal cell carcinoma WP4018,0.5477758408011765,0.997962437987243,0.6006627389329275,"['PDGFRA', 'FLT1', 'TPI1', 'ENO2', 'ACACB', 'HK2', 'EGFR', 'LDHC', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA']",0.9999958129031761,0,0,15
300,Genotoxicity pathway WP4286,0.5489291133089267,1.0053829305416342,0.6030145716570839,"['IKBIP', 'ACTA2', 'CDKN1A', 'CEBPD', 'BLOC1S2', 'PCDH8', 'HIST1H1E', 'TRIAP1', 'TRIM22', 'HIST1H2BC']",0.9999958129031761,0,0,10
301,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.5501668534674264,1.508216744392627,0.901210296721736,['FMO2'],0.9999958129031761,0,0,1
302,GABA metabolism (aka GHB) WP4157,0.5501668534674264,1.508216744392627,0.901210296721736,['PON3'],0.9999958129031761,0,0,1
303,Sulindac Metabolic Pathway WP2542,0.5501668534674264,1.508216744392627,0.901210296721736,['CYP1B1'],0.9999958129031761,0,0,1
304,Monoamine Transport WP727,0.5557249046990562,1.0282612650858147,0.6040848641201699,"['ADORA2A', 'IL1R1', 'TGFB1I1', 'TNFRSF11B', 'AGT']",0.9999958129031761,0,0,5
305,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.5642806874868228,1.1311229590136622,0.6472324916832279,"['IL10RA', 'HMOX1']",0.9999958129031761,0,0,2
306,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5642806874868228,1.1311229590136622,0.6472324916832279,"['SOCS3', 'CHI3L1']",0.9999958129031761,0,0,2
307,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5642806874868228,1.1311229590136622,0.6472324916832279,"['KLF4', 'ELK1']",0.9999958129031761,0,0,2
308,Type 2 papillary renal cell carcinoma WP4241,0.5661090835587407,1.005375746116487,0.5720271223752751,"['CDKN1A', 'EGLN3', 'EGLN2', 'EPAS1', 'TFEB', 'ELOB']",0.9999958129031761,0,0,6
309,MECP2 and Associated Rett Syndrome WP3584,0.5662309772410461,0.9870338287590043,0.5613786456789955,"['GABRR2', 'ARHGEF26', 'CEBPD', 'BCL6', 'DLX5', 'BDNF', 'SST', 'DLX6', 'GAD1', 'SGK1', 'FGF2', 'FKBP5']",0.9999958129031761,0,0,12
310,Glutathione metabolism WP100,0.5741439343172496,1.0440769230769231,0.5793323470785691,"['GGT5', 'GPX4', 'GPX3']",0.9999958129031761,0,0,3
311,Hypertrophy Model WP516,0.5741439343172496,1.0440769230769231,0.5793323470785691,"['NR4A3', 'MSTN', 'IL1R1']",0.9999958129031761,0,0,3
312,Mammalian disorder of sexual development WP4842,0.5741439343172496,1.0440769230769231,0.5793323470785691,"['EMX2', 'FST', 'SOX9']",0.9999958129031761,0,0,3
313,MAPK pathway in congenital thyroid cancer WP4928,0.5741439343172496,1.0440769230769231,0.5793323470785691,"['JUN', 'ELK1', 'MAPK3']",0.9999958129031761,0,0,3
314,NOTCH1 regulation of endothelial cell calcification WP3413,0.5741439343172496,1.0440769230769231,0.5793323470785691,"['NOTCH1', 'LPAR1', 'ALPL']",0.9999958129031761,0,0,3
315,Hedgehog Signaling Pathway WP4249,0.575193472157351,0.9896320093457944,0.5473148164498679,"['EVC2', 'PTCH1', 'BOC', 'LRP2', 'GLI1', 'GLI3', 'GLI2']",0.9999958129031761,0,0,7
316,Endoderm differentiation WP2853,0.5784520248757321,0.9756168149916793,0.5340523186640612,"['VAV3', 'DUSP4', 'DUSP5', 'DUSP2', 'TCF7L1', 'NOTCH1', 'ONECUT1', 'LEF1', 'PBX3', 'WNT8A', 'ZIC5', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'FOXO1', 'GLI2', 'DAB2', 'HHEX', 'ZIC3', 'RGS10', 'NODAL']",0.9999958129031761,0,0,22
317,Integrin-mediated Cell Adhesion WP185,0.5817837704812654,0.9733990690733973,0.5272478634222478,"['VAV3', 'SHC3', 'ITGAM', 'CAV3', 'ITGB5', 'ITGB4', 'ITGB2', 'ITGA10', 'SELENOP', 'ITGAX', 'ITGA8', 'RHO', 'ITGB8', 'ITGA6', 'HRAS', 'DOCK1', 'TNS1']",0.9999958129031761,0,0,17
318,Circadian rhythm related genes WP3594,0.5843354200428759,0.9736756019141618,0.5231365360984673,"['TPH1', 'MAGEL2', 'PHLPP1', 'AHCY', 'CHRM1', 'OPRL1', 'ATOH7', 'PROKR2', 'NFIL3', 'DRD3', 'SKP1', 'CHRNB2', 'KLF10', 'NTRK1', 'EGR1', 'NGFR', 'JUN', 'ZFHX3', 'EGR3', 'CARTPT', 'HCRTR2', 'HCRTR1', 'PER2', 'F7', 'STAR', 'ADORA2A', 'LEP', 'BHLHE40', 'CRH', 'ID3', 'UTS2']",0.9999958129031761,0,0,31
319,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5878162171927575,0.9693057946069994,0.5150318479187581,"['KLB', 'NOTCH1', 'UCP1', 'DIO3', 'TRH', 'FOXO1', 'TSHR', 'MC4R', 'SLCO1C1', 'TPO', 'NHSL1', 'TG', 'PAX8', 'PRDM16', 'HRAS']",0.9999958129031761,0,0,15
320,IL17 signaling pathway WP2112,0.590283552648239,0.9834817414508222,0.5184446225010334,"['CEBPB', 'CEBPD', 'IL17RE', 'IL17RB', 'MAPK3']",0.9999958129031761,0,0,5
321,Oxidative Stress WP408,0.590283552648239,0.9834817414508222,0.5184446225010334,"['GPX3', 'HMOX1', 'CYBB', 'XDH', 'SOD3']",0.9999958129031761,0,0,5
322,Signal transduction through IL1R WP4496,0.590283552648239,0.9834817414508222,0.5184446225010334,"['NFKBIA', 'JUN', 'IL1R1', 'TOLLIP', 'IRAK3']",0.9999958129031761,0,0,5
323,Ras signaling WP4223,0.5929985396687317,0.9691509297967421,0.5064427493617888,"['SHC4', 'CSF1R', 'SHC3', 'FLT1', 'PLA2G5', 'FOXO4', 'RASAL3', 'ELK1', 'ETS2', 'EGFR', 'GNG3', 'PLCG2', 'HRAS', 'MAPK3', 'NTRK1', 'PDGFRA', 'NGFR', 'PLA2G12B', 'PLA2G4D', 'PLA2G4E', 'GAB1', 'GNG11', 'ZAP70', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'PLA1A', 'EPHA2', 'ARF6']",0.9999958129031761,0,0,30
324,Notch Signaling Pathway Netpath WP61,0.5976425470399142,0.9624585024631943,0.49543749788565206,"['NOTCH2', 'NOTCH3', 'CDKN1A', 'NOTCH1', 'MAML2', 'HEY1', 'HEY2', 'HES1', 'HES5', 'SKP1']",0.9999958129031761,0,0,10
325,Copper homeostasis WP3286,0.6037808036823612,0.9595723591050694,0.4841465288648653,"['PRNP', 'JUN', 'STEAP4', 'SCO2', 'XAF1', 'SOD3', 'FOXO1']",0.9999958129031761,0,0,7
326,Phosphodiesterases in neuronal function WP4222,0.6156008232265407,0.9467539730624038,0.4593238815591059,"['ADCY10', 'PDE10A', 'ADORA2A', 'PDE6H', 'ADCY4', 'PDE6C', 'PDE5A', 'CHRFAM7A', 'PDE6A']",0.9999958129031761,0,0,9
327,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.6176353279323241,0.9694285714285714,0.46712602064341757,"['TNC', 'VIM', 'MAPK3']",0.9999958129031761,0,0,3
328,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.6186128273949908,1.0053685808434225,0.48285408160590115,"['HMGCS1', 'HMGCR']",0.9999958129031761,0,0,2
329,"NAD metabolism, sirtuins and aging WP3630",0.6186128273949908,1.0053685808434225,0.48285408160590115,"['ROS1', 'FOXO1']",0.9999958129031761,0,0,2
330,Serotonin Transporter Activity WP1455,0.6186128273949908,1.0053685808434225,0.48285408160590115,"['IL1R1', 'TGFB1I1']",0.9999958129031761,0,0,2
331,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6198758841233458,0.9523876379845914,0.45546606194487144,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999958129031761,0,0,4
332,miRNAs involvement in the immune response in sepsis WP4329,0.6233032205219706,0.9424338447854125,0.44550937057833917,"['NFKBIA', 'VCAM1', 'IRF7', 'TLR7', 'TLR4']",0.9999958129031761,0,0,5
333,SARS-CoV-2 mitochondrial interactions WP5038,0.6233032205219706,0.9424338447854125,0.44550937057833917,"['IFIH1', 'IRF7', 'CGAS', 'TLR7', 'TLR3']",0.9999958129031761,0,0,5
334,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6255877610301026,0.950034143946363,0.44562648652177844,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'EIF5A2', 'WNT8A', 'LRP5', 'FOXM1', 'CLDN20', 'HRAS', 'MAPK3', 'WNT10A', 'FZD2', 'GDF15', 'MMP2', 'FZD9', 'WNT9A', 'WNT16', 'TGFBR2', 'CLDN5', 'CLDN10', 'LATS2', 'CLDN9', 'COL4A6', 'COL4A5', 'STRAP']",0.9999958129031761,0,0,25
335,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6272174646887605,0.9359014186600394,0.4365624146519221,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'IFI27', 'MAPK3']",0.9999958129031761,0,0,6
336,IL-6 signaling pathway WP364,0.6313242540060158,0.9312809235843871,0.42832932039144006,"['SOCS3', 'HCK', 'GAB1', 'VIP', 'AGT', 'VAV1', 'MAPK3']",0.9999958129031761,0,0,7
337,Benzene metabolism WP3891,0.6316167009969011,1.1310792804796803,0.5196998864419289,['EPHX1'],0.9999958129031761,0,0,1
338,MED and Pseudoachondroplasia genes WP4789,0.6316167009969011,1.1310792804796803,0.5196998864419289,['COL9A1'],0.9999958129031761,0,0,1
339,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.6316167009969011,1.1310792804796803,0.5196998864419289,['NRP1'],0.9999958129031761,0,0,1
340,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.6316167009969011,1.1310792804796803,0.5196998864419289,['FOXO1'],0.9999958129031761,0,0,1
341,Steroid Biosynthesis WP496,0.6316167009969011,1.1310792804796803,0.5196998864419289,['HSD3B1'],0.9999958129031761,0,0,1
342,TNF-alpha signaling pathway WP231,0.6448835153078338,0.929265005226385,0.40765515306875244,"['HSP90AA1', 'JUN', 'TNFAIP3', 'CYBA', 'TNFRSF1B', 'SELE', 'NFKBIA', 'CASP7', 'RFK', 'CCL2', 'MAP3K8', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999958129031761,0,0,15
343,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6546717424207346,0.9046697798532355,0.3832374113512392,"['HPGD', 'CYP4A11', 'TBXAS1', 'PLA2G5', 'PTGDR']",0.9999958129031761,0,0,5
344,Endothelin Pathways WP2197,0.6546717424207346,0.9046697798532355,0.3832374113512392,"['ADCY10', 'ATP2A2', 'ADRB1', 'CALM1', 'CALM2']",0.9999958129031761,0,0,5
345,Type II interferon signaling (IFNG) WP619,0.6546717424207346,0.9046697798532355,0.3832374113512392,"['SOCS3', 'OAS1', 'CYBB', 'IRF8', 'PSMB9']",0.9999958129031761,0,0,5
346,Angiogenesis WP1539,0.654940634738458,0.904701567189063,0.3828793667512584,"['PDGFRA', 'FLT1', 'TIMP2', 'FGF2']",0.9999958129031761,0,0,4
347,Unfolded protein response WP4925,0.654940634738458,0.904701567189063,0.3828793667512584,"['PPP1R15A', 'XBP1', 'PMAIP1', 'TXNIP']",0.9999958129031761,0,0,4
348,Urea cycle and associated pathways WP4595,0.654940634738458,0.904701567189063,0.3828793667512584,"['SLC25A15', 'OAT', 'GOT1', 'MDH2']",0.9999958129031761,0,0,4
349,Methionine De Novo and Salvage Pathway WP3580,0.6580026424502494,0.9047333333333333,0.378672817908514,"['AHCY', 'ODC1', 'MAT2B']",0.9999958129031761,0,0,3
350,Nicotine Activity on Dopaminergic Neurons WP1602,0.6580026424502494,0.9047333333333333,0.378672817908514,"['CHRNB2', 'DRD3', 'SLC18A2']",0.9999958129031761,0,0,3
351,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6580026424502494,0.9047333333333333,0.378672817908514,"['MDH2', 'IDH3B', 'SUCLG2']",0.9999958129031761,0,0,3
352,Biomarkers for urea cycle disorders WP4583,0.6675592675991548,0.904765078307231,0.3656400893030254,"['F7', 'GOT1']",0.9999958129031761,0,0,2
353,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.6675592675991548,0.904765078307231,0.3656400893030254,"['BMPR1B', 'SMAD6']",0.9999958129031761,0,0,2
354,Iron metabolism in placenta WP2007,0.6675592675991548,0.904765078307231,0.3656400893030254,"['HEPHL1', 'HAMP']",0.9999958129031761,0,0,2
355,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.6675592675991548,0.904765078307231,0.3656400893030254,"['PGR', 'VIM']",0.9999958129031761,0,0,2
356,Purine metabolism WP4792,0.6675592675991548,0.904765078307231,0.3656400893030254,"['PRPS1', 'XDH']",0.9999958129031761,0,0,2
357,RalA downstream regulated genes WP2290,0.6675592675991548,0.904765078307231,0.3656400893030254,"['YBX3', 'HRAS']",0.9999958129031761,0,0,2
358,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6685659045550838,0.9044786096256684,0.36416145057788596,"['PSMD8', 'TUBB8', 'TUBA1C', 'TUBB2A', 'TUBB3', 'TUBB', 'CASP1', 'STUB1', 'TUBA4A', 'HSPA1B', 'HSPA1A']",0.9999958129031761,0,0,11
359,Neovascularisation processes WP4331,0.6830165117922791,0.8753915205528109,0.33373097559833126,"['ACVRL1', 'NOTCH3', 'NOTCH1', 'CXCR4', 'EPHB4', 'MAPK3']",0.9999958129031761,0,0,6
360,Phosphoinositides metabolism WP4971,0.6830165117922791,0.8753915205528109,0.33373097559833126,"['PIP4P1', 'PLCZ1', 'INPP5D', 'PLCG2', 'PIP4K2A', 'PIP4K2C']",0.9999958129031761,0,0,6
361,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6837745498494295,0.8824463536788957,0.33544170377043714,"['CD160', 'CXCL17', 'IRF7', 'CCL2', 'CXCL1', 'TLR7', 'CXCL13', 'CXCL5']",0.9999958129031761,0,0,8
362,Prion disease pathway WP3995,0.6843131976399349,0.8698106429927644,0.32995359953319653,"['PRNP', 'EBF1', 'ELK1', 'MAPK3', 'BATF']",0.9999958129031761,0,0,5
363,Tumor suppressor activity of SMARCB1 WP4204,0.6843131976399349,0.8698106429927644,0.32995359953319653,"['CDKN2A', 'PTCH1', 'GLI1', 'GLI3', 'GLI2']",0.9999958129031761,0,0,5
364,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6877594590410743,0.8615570269454897,0.322494688368401,"['WIF1', 'LEF1', 'LRP5', 'DKK1']",0.9999958129031761,0,0,4
365,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.6983226578461589,0.904796802131912,0.3248890272908616,['CYP2J2'],0.9999958129031761,0,0,1
366,Effects of nitric oxide WP1995,0.6983226578461589,0.904796802131912,0.3248890272908616,['XDH'],0.9999958129031761,0,0,1
367,Hfe effect on hepcidin production WP3924,0.6983226578461589,0.904796802131912,0.3248890272908616,['HAMP'],0.9999958129031761,0,0,1
368,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.6983226578461589,0.904796802131912,0.3248890272908616,['CDKN1A'],0.9999958129031761,0,0,1
369,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.6983226578461589,0.904796802131912,0.3248890272908616,['SIX4'],0.9999958129031761,0,0,1
370,miRNA Biogenesis WP2338,0.6983226578461589,0.904796802131912,0.3248890272908616,['RAN'],0.9999958129031761,0,0,1
371,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.6983226578461589,0.904796802131912,0.3248890272908616,['ROBO4'],0.9999958129031761,0,0,1
372,Somatic sex determination WP4814,0.6983226578461589,0.904796802131912,0.3248890272908616,['SOX9'],0.9999958129031761,0,0,1
373,p53 transcriptional gene network WP4963,0.7070367996919453,0.869593153255031,0.30146408803792785,"['CDKN1A', 'NOTCH1', 'ADORA2B', 'CCL2', 'PMAIP1', 'SLC7A11', 'THBS1', 'CX3CL1', 'RPRM', 'TNFRSF10D']",0.9999958129031761,0,0,10
374,Prolactin Signaling Pathway WP2037,0.7092746784357012,0.8751415536933381,0.30062198488554903,"['NFKBIA', 'ZAP70', 'SOCS3', 'JUN', 'CISH', 'PTPN6', 'ELK1', 'HRAS', 'PRLR', 'YWHAG', 'VAV1', 'MAPK3']",0.9999958129031761,0,0,12
375,Amino Acid metabolism WP3925,0.7107401166602652,0.8772874756651525,0.29954843478245946,"['AOC3', 'TPH1', 'OAT', 'GOT1', 'MDH2', 'ODC1', 'ACLY', 'TPO', 'LDHA', 'PKM', 'ALDH1A1', 'PDK4', 'ACSS1']",0.9999958129031761,0,0,13
376,Homologous recombination WP186,0.711288865406609,0.8224531216867105,0.28019057528913904,"['RAD51', 'POLD1']",0.9999958129031761,0,0,2
377,Osteopontin Signaling WP1434,0.711288865406609,0.8224531216867105,0.28019057528913904,"['SPP1', 'MAPK3']",0.9999958129031761,0,0,2
378,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7121839828622465,0.8375336644182542,0.28427483721336055,"['HEXIM1', 'NFKBIA', 'SUPT4H1', 'NFATC2', 'NFATC1']",0.9999958129031761,0,0,5
379,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7183012751731059,0.8223347176331505,0.2720827587416657,"['CDKN1A', 'PTH1R', 'SOX9', 'MAPK3']",0.9999958129031761,0,0,4
380,16p11.2 proximal deletion syndrome WP4949,0.726593517420493,0.8575050709939148,0.2738768991019461,"['SPN', 'PARP4', 'MVP', 'MSN', 'GDPD3', 'TBX6', 'ALDOA', 'SEZ6L2', 'CDIPT', 'YPEL3', 'MAPK3']",0.9999958129031761,0,0,11
381,Triacylglyceride synthesis WP325,0.7292356909987512,0.7981764705882353,0.2520308390336002,"['LPL', 'AGPAT1', 'PLPP3']",0.9999958129031761,0,0,3
382,Vitamin D in inflammatory diseases WP4482,0.7292356909987512,0.7981764705882353,0.2520308390336002,"['NFKBIA', 'VDR', 'NFATC1']",0.9999958129031761,0,0,3
383,PDGF Pathway WP2526,0.7330581891468838,0.8222161555494889,0.255322943382636,"['NFKBIA', 'JUN', 'ELK1', 'HRAS', 'VAV1', 'MAPK3']",0.9999958129031761,0,0,6
384,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7330581891468838,0.8222161555494889,0.255322943382636,"['NFKBIA', 'CASP7', 'JUN', 'TNFRSF12A', 'CCL2', 'MAPK3']",0.9999958129031761,0,0,6
385,MAPK Cascade WP422,0.7382687580093801,0.8075621843133518,0.24505260473463336,"['JUN', 'ELK1', 'HRAS', 'SIPA1', 'MAPK3']",0.9999958129031761,0,0,5
386,Hepatitis B infection WP4666,0.7408011415737216,0.8799268523658688,0.26399834211546497,"['JUN', 'EGR2', 'CDKN1A', 'TICAM2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'NFATC2', 'NFATC1', 'ELK1', 'TGFBR2', 'IFIH1', 'CASP10', 'CREB3L1', 'IRF7', 'CYCS', 'HRAS', 'TLR4', 'TLR3', 'TLR2', 'MAPK3']",0.9999958129031761,0,0,22
387,Glioblastoma signaling pathways WP2261,0.7443299996552097,0.8517328292375551,0.2514918292449433,"['PDGFRA', 'CDKN1A', 'PRKCH', 'CDKN2A', 'GAB1', 'FOXO4', 'FOXO1', 'EGFR', 'ERBB3', 'CDK2', 'PLCG2', 'HRAS', 'MAPK3']",0.9999958129031761,0,0,13
388,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7465753937720144,0.7865230439131885,0.22986817933385523,"['CXCL1', 'SOX9', 'FGF2', 'GLI2']",0.9999958129031761,0,0,4
389,RANKL/RANK signaling pathway WP2018,0.7482716451433912,0.8220974351191379,0.23839938162514232,"['LYN', 'NFKBIA', 'JUN', 'VCAM1', 'SYK', 'TNFRSF11B', 'NFATC1', 'MAPK3']",0.9999958129031761,0,0,8
390,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7500858160082535,0.7538598245029434,0.21678570393106258,"['TULP3', 'PMAIP1']",0.9999958129031761,0,0,2
391,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.7529529021985812,0.7539418165667333,0.21393295071417176,['CASP1'],0.9999958129031761,0,0,1
392,"Cerebral organic acidurias, including diseases WP4519",0.7529529021985812,0.7539418165667333,0.21393295071417176,['MDH2'],0.9999958129031761,0,0,1
393,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.7529529021985812,0.7539418165667333,0.21393295071417176,['DHCR24'],0.9999958129031761,0,0,1
394,Disorders of the Krebs cycle WP4236,0.7529529021985812,0.7539418165667333,0.21393295071417176,['SUCLG2'],0.9999958129031761,0,0,1
395,Glial Cell Differentiation WP2276,0.7529529021985812,0.7539418165667333,0.21393295071417176,['MSN'],0.9999958129031761,0,0,1
396,Molybdenum cofactor (Moco) biosynthesis WP4507,0.7529529021985812,0.7539418165667333,0.21393295071417176,['XDH'],0.9999958129031761,0,0,1
397,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7558718196768152,0.7979744450332685,0.22333985494754272,"['LYN', 'NFKBIA', 'HCK', 'CISH', 'BTK', 'MAPK3']",0.9999958129031761,0,0,6
398,Kallmann's Syndrome WP5074,0.7602110492937774,0.7537777777777778,0.20665510334711817,"['PROKR2', 'FGF8', 'CHD7']",0.9999958129031761,0,0,3
399,Gastrin signaling pathway WP4659,0.7610960526007932,0.8537322318970009,0.2330652369348057,"['CHGA', 'EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'SERPINB2', 'ANXA2', 'CDKN2A', 'KLF4', 'ELK1', 'FOXO1', 'EGFR', 'NFKBIA', 'CCKBR', 'HRAS', 'CD44', 'MAPK3']",0.9999958129031761,0,0,17
400,Amyotrophic lateral sclerosis (ALS) WP2447,0.7625764194327287,0.7796577028363737,0.21132821106599226,"['SLC1A2', 'CASP1', 'NEFL', 'NEFM', 'NEFH']",0.9999958129031761,0,0,5
401,Wnt signaling in kidney disease WP4150,0.7625764194327287,0.7796577028363737,0.21132821106599226,"['WNT10A', 'FZD2', 'LRP5', 'FZD9', 'WNT16']",0.9999958129031761,0,0,5
402,Melanoma WP4685,0.7627233683796426,0.8219785560246636,0.22264100586537955,"['PREX2', 'CDKN1A', 'GADD45B', 'CDKN2A', 'CALM3', 'CALM1', 'ELK1', 'HRAS', 'CALM2', 'MAPK3']",0.9999958129031761,0,0,10
403,Alzheimer's disease WP2059,0.7761854669373096,0.8218595179477828,0.20822943703074337,"['ATP5MD', 'CASP7', 'ATP2A2', 'LPL', 'CYCS', 'CALM3', 'APOE', 'CALM1', 'CALM2', 'RYR3', 'MAPK3', 'CDK5R1']",0.9999958129031761,0,0,12
404,Biomarkers for pyrimidine metabolism disorders WP4584,0.7843023857734951,0.6958193422705252,0.16905671053317164,"['RRM2', 'UPB1']",0.9999958129031761,0,0,2
405,Cell Differentiation - Index expanded WP2023,0.7843023857734951,0.6958193422705252,0.16905671053317164,"['PAX7', 'KLF4']",0.9999958129031761,0,0,2
406,Cholesterol Biosynthesis Pathway WP197,0.7843023857734951,0.6958193422705252,0.16905671053317164,"['HMGCS1', 'HMGCR']",0.9999958129031761,0,0,2
407,GPR40 Pathway WP3958,0.7843023857734951,0.6958193422705252,0.16905671053317164,"['PLCZ1', 'PLCG2']",0.9999958129031761,0,0,2
408,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7843023857734951,0.6958193422705252,0.16905671053317164,"['FRAT1', 'SOX9']",0.9999958129031761,0,0,2
409,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.7843023857734951,0.6958193422705252,0.16905671053317164,"['HMGCS1', 'HMGCR']",0.9999958129031761,0,0,2
410,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.7843023857734951,0.6958193422705252,0.16905671053317164,"['ACLY', 'SUCLG2']",0.9999958129031761,0,0,2
411,Fatty Acid Biosynthesis WP357,0.788247800035435,0.7140526315789474,0.16990366216091318,"['ACLY', 'ECHDC3', 'ACACB']",0.9999958129031761,0,0,3
412,Hippo-Yap signaling pathway WP4537,0.788247800035435,0.7140526315789474,0.16990366216091318,"['LATS2', 'TEAD2', 'TEAD3']",0.9999958129031761,0,0,3
413,NAD+ biosynthetic pathways WP3645,0.788247800035435,0.7140526315789474,0.16990366216091318,"['PARP4', 'CD38', 'ACMSD']",0.9999958129031761,0,0,3
414,NRF2-ARE regulation WP4357,0.788247800035435,0.7140526315789474,0.16990366216091318,"['CEBPB', 'HMOX1', 'SLC7A11']",0.9999958129031761,0,0,3
415,PKC-gamma calcium signaling pathway in ataxia WP4760,0.788247800035435,0.7140526315789474,0.16990366216091318,"['GNA14', 'CA8', 'RYR3']",0.9999958129031761,0,0,3
416,Androgen receptor signaling pathway WP138,0.7896815637639754,0.8160628019323671,0.19269323601499785,"['CDKN1A', 'JUN', 'TGFB1I1', 'LIMK2', 'RNF6', 'ETV5', 'FOXO1', 'EGFR', 'KAT2B', 'STUB1', 'FKBP4', 'RAN', 'RAD9A']",0.9999958129031761,0,0,13
417,PDGFR-beta pathway WP3972,0.7965152905493421,0.7234944981660554,0.1646014755199956,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999958129031761,0,0,4
418,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7965152905493421,0.7234944981660554,0.1646014755199956,"['TFEB', 'FOXO4', 'HRAS', 'FOXO1']",0.9999958129031761,0,0,4
419,Sphingolipid pathway WP1422,0.7965152905493421,0.7234944981660554,0.1646014755199956,"['CERS4', 'ACER1', 'SPTLC3', 'SERINC1']",0.9999958129031761,0,0,4
420,Disorders of Folate Metabolism and Transport WP4259,0.797692888644446,0.6461882554487485,0.1460589697579563,['ALDH1L1'],0.9999958129031761,0,0,1
421,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.797692888644446,0.6461882554487485,0.1460589697579563,['ELOB'],0.9999958129031761,0,0,1
422,Liver X receptor pathway WP2874,0.797692888644446,0.6461882554487485,0.1460589697579563,['CYP3A4'],0.9999958129031761,0,0,1
423,Methylation Pathways WP704,0.797692888644446,0.6461882554487485,0.1460589697579563,['MAT2B'],0.9999958129031761,0,0,1
424,Mitochondrial CII Assembly WP4920,0.797692888644446,0.6461882554487485,0.1460589697579563,['SDHAF1'],0.9999958129031761,0,0,1
425,Regulation of Actin Cytoskeleton WP51,0.7997608362059004,0.8423291012571142,0.18821216295812862,"['PDGFRA', 'CHRM1', 'GSN', 'MSN', 'BRK1', 'FGF2', 'VAV1', 'EGFR', 'ACTG1', 'PIK3R5', 'FGF17', 'VIL1', 'FGF8', 'DIAPH3', 'PIP4K2A', 'PIP4K2C', 'CD14', 'FGFR4', 'DOCK1', 'WASF2', 'FGF10', 'MAPK3']",0.9999958129031761,0,0,22
426,Cytosolic DNA-sensing pathway WP4655,0.8029533843643536,0.769452633822328,0.1688630120741342,"['NFKBIA', 'IL33', 'CASP10', 'CASP1', 'IRF7', 'POLR2E', 'CGAS', 'POLR2K']",0.9999958129031761,0,0,8
427,IL-1 signaling pathway WP195,0.8029533843643536,0.769452633822328,0.1688630120741342,"['NFKBIA', 'JUN', 'IL1R1', 'TOLLIP', 'PELI2', 'CCL2', 'IRAK3', 'MAPK3']",0.9999958129031761,0,0,8
428,Nuclear receptors WP170,0.8059940894445032,0.7292496072650584,0.15728373102249393,"['NR4A1', 'VDR', 'NR0B1', 'PGR', 'NR2F2']",0.9999958129031761,0,0,5
429,Leptin signaling pathway WP2034,0.807600556989539,0.789157329598506,0.1686332169560702,"['SOCS3', 'GSK3A', 'CISH', 'LEP', 'LEPR', 'PLCG2', 'ELK1', 'HRAS', 'ACACB', 'FOXO1', 'MAPK3']",0.9999958129031761,0,0,11
430,Ectoderm Differentiation WP2858,0.8103729456366593,0.8289788926239516,0.17430169100863901,"['TFAP2C', 'TCF7L1', 'EDA', 'ARHGDIG', 'STC1', 'TNFRSF11B', 'NFATC1', 'PAX6', 'NR2F2', 'JAKMIP1', 'ZFHX4', 'EDA2R', 'GLI3', 'PPFIBP2', 'MAFB', 'BOC', 'PIM1', 'CCL2', 'TBL1X', 'LY6E']",0.9999958129031761,0,0,20
431,DNA Mismatch Repair WP531,0.8135035462299586,0.6783,0.14000450682449733,"['POLD1', 'RPA3', 'POLE3']",0.9999958129031761,0,0,3
432,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8143249700880111,0.646070357499881,0.13270011628955347,"['MKNK2', 'MAPK3']",0.9999958129031761,0,0,2
433,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8143249700880111,0.646070357499881,0.13270011628955347,"['SYTL4', 'SYTL3']",0.9999958129031761,0,0,2
434,Glycosaminoglycan degradation WP4815,0.8143249700880111,0.646070357499881,0.13270011628955347,"['HPSE2', 'IDS']",0.9999958129031761,0,0,2
435,NAD+ metabolism WP3644,0.8143249700880111,0.646070357499881,0.13270011628955347,"['NRK', 'CD38']",0.9999958129031761,0,0,2
436,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8143249700880111,0.646070357499881,0.13270011628955347,"['SFRP4', 'LEF1']",0.9999958129031761,0,0,2
437,Type II diabetes mellitus WP1584,0.8143249700880111,0.646070357499881,0.13270011628955347,"['KCNJ11', 'PIK3R5']",0.9999958129031761,0,0,2
438,Base Excision Repair WP4752,0.8183373399199492,0.6956164875471311,0.13945763263645514,"['FEN1', 'NEIL2', 'POLD1', 'POLE3']",0.9999958129031761,0,0,4
439,G13 Signaling Pathway WP524,0.8252093052495075,0.7064084389593062,0.13571393293977935,"['RTKN', 'ARHGDIG', 'PIP4K2A', 'CALM1', 'CALM2']",0.9999958129031761,0,0,5
440,Endometrial cancer WP4155,0.8289405835680386,0.7532843464707192,0.14132126485037905,"['CDKN1A', 'TCF7L1', 'GADD45B', 'LEF1', 'FGF2', 'ELK1', 'HRAS', 'EGFR', 'MAPK3']",0.9999958129031761,0,0,9
441,Pathways affected in adenoid cystic carcinoma WP3651,0.8289405835680386,0.7532843464707192,0.14132126485037905,"['CEBPA', 'NOTCH1', 'UHRF1', 'CHEK2', 'INSRR', 'ERBIN', 'HIST1H1E', 'FGFR4', 'HRAS']",0.9999958129031761,0,0,9
442,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8303050728490644,0.8212619316275808,0.15272358366179498,"['NSF', 'SHC4', 'VAV3', 'NTRK1', 'NGFR', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'SHC3', 'NCF1', 'BDNF', 'ELK1', 'ACACB', 'NFKBIA', 'RPS6KA5', 'IGF2BP1', 'SPP1', 'ALPL', 'HRAS', 'MAPK3', 'CDK5R1']",0.9999958129031761,0,0,22
443,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8314866821641314,0.7746668577160052,0.14295701968960284,"['SHC4', 'PDGFRA', 'SHC3', 'ERBB3', 'AXL', 'HGF', 'GAB1', 'PLCG2', 'FGF2', 'HRAS', 'EGFR', 'MAPK3']",0.9999958129031761,0,0,12
444,ATR Signaling WP3875,0.8343326579030343,0.5653730846102598,0.10240211769235459,['RAD9A'],0.9999958129031761,0,0,1
445,Biotin Metabolism (including IEMs) WP5031,0.8343326579030343,0.5653730846102598,0.10240211769235459,['ACACB'],0.9999958129031761,0,0,1
446,"Degradation pathway of sphingolipids, including diseases WP4153",0.8343326579030343,0.5653730846102598,0.10240211769235459,['NEU1'],0.9999958129031761,0,0,1
447,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.8343326579030343,0.5653730846102598,0.10240211769235459,['TIFA'],0.9999958129031761,0,0,1
448,NLR Proteins WP288,0.8343326579030343,0.5653730846102598,0.10240211769235459,['ERBIN'],0.9999958129031761,0,0,1
449,Urea cycle and related diseases WP4571,0.8343326579030343,0.5653730846102598,0.10240211769235459,['SLC25A15'],0.9999958129031761,0,0,1
450,Gastric Cancer Network 1 WP2361,0.8361553489365114,0.645952380952381,0.11558727396842193,"['NOTCH1', 'MCM4', 'GATD3A']",0.9999958129031761,0,0,3
451,Head and Neck Squamous Cell Carcinoma WP4674,0.8381913909265828,0.7532019155807996,0.13294677716057687,"['NOTCH2', 'CDKN1A', 'NOTCH1', 'TERT', 'CDKN2A', 'GAB1', 'HRAS', 'EGFR', 'TGFBR2', 'PIK3R5']",0.9999958129031761,0,0,10
452,miRNA regulation of prostate cancer signaling pathways WP3981,0.838192733045858,0.6698035147518309,0.1182251518089375,"['NFKBIA', 'CDKN1A', 'CREB3L1', 'FOXO1']",0.9999958129031761,0,0,4
453,Translation Factors WP107,0.8405294195324334,0.7190951571792693,0.12492360121328566,"['EIF4A2', 'EEF1G', 'EIF1AY', 'EIF1AX', 'EEF1A2', 'EIF4H', 'GSPT2']",0.9999958129031761,0,0,7
454,Canonical and non-canonical TGF-B signaling WP3874,0.8405502036355574,0.602954570698656,0.1047323631288634,"['LOXL1', 'TGFBR2']",0.9999958129031761,0,0,2
455,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.8405502036355574,0.602954570698656,0.1047323631288634,"['JUN', 'MAPK3']",0.9999958129031761,0,0,2
456,Pyrimidine metabolism and related diseases WP4225,0.8405502036355574,0.602954570698656,0.1047323631288634,"['RRM2', 'UPB1']",0.9999958129031761,0,0,2
457,BDNF-TrkB Signaling WP3676,0.8561939474365585,0.6458343257276234,0.1002711746251165,"['ARC', 'BDNF', 'GAB1', 'HRAS']",0.9999958129031761,0,0,4
458,EPO Receptor Signaling WP581,0.8563911100981682,0.6165454545454545,0.09558187215074887,"['PTPRC', 'CISH', 'MAPK3']",0.9999958129031761,0,0,3
459,Photodynamic therapy-induced unfolded protein response WP3613,0.8563911100981682,0.6165454545454545,0.09558187215074887,"['PPP1R15A', 'XBP1', 'DNAJB9']",0.9999958129031761,0,0,3
460,Kit receptor signaling pathway WP304,0.8612320821740652,0.7088939081475663,0.10590255507525888,"['LYN', 'INPP5D', 'BTK', 'PTPN6', 'HRAS', 'VAV1', 'MAPK3', 'TBX2']",0.9999958129031761,0,0,8
461,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8633685964782607,0.5652282572475842,0.08303970026056322,"['HRAS', 'MAPK3']",0.9999958129031761,0,0,2
462,Autosomal recessive Osteopetrosis pathways WP4788,0.8643383592088374,0.5025168406247686,0.07326241632258848,['TCIRG1'],0.9999958129031761,0,0,1
463,Dopamine metabolism WP2436,0.8643383592088374,0.5025168406247686,0.07326241632258848,['TYR'],0.9999958129031761,0,0,1
464,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.8643383592088374,0.5025168406247686,0.07326241632258848,['MAFK'],0.9999958129031761,0,0,1
465,TCA cycle in senescence WP5050,0.8643383592088374,0.5025168406247686,0.07326241632258848,['GOT1'],0.9999958129031761,0,0,1
466,Valproic acid pathway WP3871,0.8643383592088374,0.5025168406247686,0.07326241632258848,['CYP2A6'],0.9999958129031761,0,0,1
467,TGF-beta Signaling Pathway WP366,0.8688952089413193,0.7800511820619059,0.10962273704436486,"['KLF10', 'YAP1', 'JUN', 'CDKN1A', 'CITED1', 'ITGB4', 'TGFB1I1', 'LIMK2', 'TNC', 'THBS1', 'TGFBR2', 'TGFBR3', 'DAB2', 'COL1A2', 'PARD6A', 'TERT', 'STRAP', 'FOSB', 'SKP1']",0.9999958129031761,0,0,19
468,Ebstein-Barr virus LMP1 signaling WP262,0.8831537564001576,0.5319403336142854,0.06609675893227011,"['NFKBIA', 'HSP90AA1']",0.9999958129031761,0,0,2
469,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.8831537564001576,0.5319403336142854,0.06609675893227011,"['LDHA', 'ACACB']",0.9999958129031761,0,0,2
470,SARS coronavirus and innate immunity WP4912,0.8831537564001576,0.5319403336142854,0.06609675893227011,"['IFIH1', 'TLR3']",0.9999958129031761,0,0,2
471,3q29 copy number variation syndrome WP4906,0.8846585184089224,0.6820423977068699,0.08358672618830174,"['CASP7', 'TM4SF19', 'JUN', 'NCBP2', 'DYNLT3', 'SLC51A', 'DYNLL2', 'HAMP']",0.9999958129031761,0,0,8
472,p38 MAPK Signaling Pathway WP400,0.8871104906022717,0.6026897854840503,0.07219364061794016,"['RPS6KA5', 'HSPB1', 'ELK1', 'HRAS']",0.9999958129031761,0,0,4
473,Parkinson's disease pathway WP2371,0.8871104906022717,0.6026897854840503,0.07219364061794016,"['CASP7', 'PINK1', 'CASP6', 'CYCS']",0.9999958129031761,0,0,4
474,Target Of Rapamycin (TOR) Signaling WP1471,0.8871104906022717,0.6026897854840503,0.07219364061794016,"['RRAGA', 'DDIT4L', 'PRR5L', 'HMGCR']",0.9999958129031761,0,0,4
475,Lipid Metabolism Pathway WP3965,0.8903811675147993,0.5650833333333334,0.06560935632554754,"['ACLY', 'PRKAR1A', 'ACSBG1']",0.9999958129031761,0,0,3
476,ErbB signaling pathway WP673,0.8940945250164487,0.713192208203558,0.0798374293116839,"['SHC4', 'CDKN1A', 'JUN', 'SHC3', 'ERBB3', 'GAB1', 'PLCG2', 'ELK1', 'HRAS', 'FOXO1', 'EGFR', 'MAPK3']",0.9999958129031761,0,0,12
477,NO/cGMP/PKG mediated Neuroprotection WP4008,0.899295175168005,0.6107224636243982,0.06482450146664191,"['NFKBIA', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.9999958129031761,0,0,5
478,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.9002557116736136,0.5023510681624643,0.05278525781955807,"['B3GALT1', 'B4GALNT1']",0.9999958129031761,0,0,2
479,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9002684258448652,0.5832051544063075,0.06127288025172072,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9']",0.9999958129031761,0,0,4
480,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9024003799913076,0.7038778673683388,0.07228612926065335,"['ATP5F1B', 'NDUFB5', 'NDUFA4', 'UCP1', 'ATP5MC3', 'UQCRFS1', 'SLC25A5', 'COX7A1', 'COX7C', 'SLC25A4', 'UQCRH', 'SLC25A6']",0.9999958129031761,0,0,12
481,16p11.2 distal deletion syndrome WP4950,0.9045119856717739,0.54244,0.05443912818604377,"['C3', 'PLN', 'NFATC2']",0.9999958129031761,0,0,3
482,Resistin as a regulator of inflammation WP4481,0.9045119856717739,0.54244,0.05443912818604377,"['NFKBIA', 'PLCG2', 'MAPK3']",0.9999958129031761,0,0,3
483,Wnt signaling pathway and pluripotency WP399,0.9066507072089882,0.7073336825563122,0.0693172939034919,"['WNT10A', 'JUN', 'TCF7L1', 'PRKCH', 'FZD2', 'LEF1', 'FZD9', 'LRP5', 'PPM1J', 'WNT16', 'NKD1', 'FRAT1', 'CD44']",0.9999958129031761,0,0,13
484,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.9090336386277461,0.4110895766458724,0.039206919901080495,['NFKBIA'],0.9999958129031761,0,0,1
485,Wnt Signaling Pathway WP363,0.9104052267816672,0.6161616161616161,0.05783630242905151,"['GSK3A', 'FRAT1', 'GJA1', 'LEF1', 'LRP5', 'NFATC2']",0.9999958129031761,0,0,6
486,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9135638285352874,0.6453613164798474,0.05834197509250848,"['EGR1', 'JUN', 'PAX8', 'CDK2', 'CGA', 'HRAS', 'TSHR', 'MAPK3']",0.9999958129031761,0,0,8
487,Purine metabolism and related disorders WP4224,0.9149972036370719,0.4758764622318876,0.042274138059092844,"['PRPS1', 'XDH']",0.9999958129031761,0,0,2
488,Oxidative phosphorylation WP623,0.9197219731964926,0.6024246468690914,0.050413218398796734,"['ATP5F1B', 'ATP6AP1', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC3']",0.9999958129031761,0,0,6
489,Regulation of Microtubule Cytoskeleton WP2038,0.9202384277647616,0.579317835822172,0.04815433632333923,"['SPRED1', 'PARD6A', 'RHO', 'PHLDB2', 'F2RL2']",0.9999958129031761,0,0,5
490,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9235415225676671,0.6452428666857525,0.05132230672503081,"['CDKN1A', 'TCF7L1', 'JUN', 'GADD45B', 'LEF1', 'PMAIP1', 'CYCS', 'TGFBR2', 'MAPK3']",0.9999958129031761,0,0,9
491,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.9255122995853406,0.37680435265378637,0.029167617594712366,['GPRC5C'],0.9999958129031761,0,0,1
492,1q21.1 copy number variation syndrome WP4905,0.9276720932583374,0.45204931689436856,0.033938486864141054,"['GJA1', 'TJP2']",0.9999958129031761,0,0,2
493,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9276720932583374,0.45204931689436856,0.033938486864141054,"['LEF1', 'HIST1H3E']",0.9999958129031761,0,0,2
494,Interferon type I signaling pathways WP585,0.9281795154713868,0.589284937111024,0.04391947796560485,"['ZAP70', 'SOCS3', 'RPS6KA5', 'PTPRC', 'PTPN6', 'VAV1']",0.9999958129031761,0,0,6
495,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9291881253124304,0.5647931954636425,0.04148070400338181,"['ADCY10', 'ADCY4', 'BANF1', 'HRAS', 'MAPK3']",0.9999958129031761,0,0,5
496,DNA damage response (only ATM dependent) WP710,0.929815255556195,0.6869972507891253,0.04999235198462057,"['WNT10A', 'JUN', 'CDKN1A', 'TCF7L1', 'MLKL', 'BIK', 'CDKN2A', 'LEF1', 'WNT16', 'PIK3R5', 'FRAT1', 'BCL6', 'PMAIP1', 'HRAS']",0.9999958129031761,0,0,14
497,Male infertility WP4673,0.929815255556195,0.6869972507891253,0.04999235198462057,"['MMP2', 'PON2', 'HMGA1', 'TEX15', 'THBS1', 'SOD3', 'ETV5', 'CYP26B1', 'FOLH1', 'TCN2', 'MSH4', 'MSH5', 'EPSTI1', 'HLA-DRA']",0.9999958129031761,0,0,14
498,Small cell lung cancer WP4658,0.9304037180419775,0.6689203412707257,0.04825369368060048,"['NFKBIA', 'CDKN1A', 'LAMB3', 'GADD45B', 'LAMB2', 'CDK2', 'CKS2', 'COL4A6', 'COL4A5', 'CYCS', 'ITGA6', 'SKP1']",0.9999958129031761,0,0,12
499,DNA damage response WP707,0.9360314869119087,0.6124105146996407,0.04048410943454112,"['CDKN1A', 'RAD51', 'GADD45B', 'CHEK2', 'CDK2', 'PMAIP1', 'CYCS', 'RAD9A']",0.9999958129031761,0,0,8
500,Estrogen signaling pathway WP712,0.9385452383341908,0.4304914234937561,0.02730358331593238,"['JUN', 'ELK1']",0.9999958129031761,0,0,2
501,IL-7 signaling pathway WP205,0.9385452383341908,0.4304914234937561,0.02730358331593238,"['IL7', 'MAPK3']",0.9999958129031761,0,0,2
502,Sphingolipid Metabolism (general overview) WP4725,0.9385452383341908,0.4304914234937561,0.02730358331593238,"['CERS4', 'PLPP3']",0.9999958129031761,0,0,2
503,Trans-sulfuration and one-carbon metabolism WP2525,0.9385452383341908,0.4304914234937561,0.02730358331593238,"['AHCY', 'MAT2B']",0.9999958129031761,0,0,2
504,IL-9 signaling pathway WP22,0.9390065759227089,0.3477937785066366,0.021887635151351212,['MAPK3'],0.9999958129031761,0,0,1
505,Omega-3/Omega-6 FA synthesis WP4723,0.9390065759227089,0.3477937785066366,0.021887635151351212,['PLA2G5'],0.9999958129031761,0,0,1
506,Riboflavin and CoQ disorders WP5037,0.9390065759227089,0.3477937785066366,0.021887635151351212,['RFK'],0.9999958129031761,0,0,1
507,Common Pathways Underlying Drug Addiction WP2636,0.947693592001896,0.5020191915823793,0.02697050121787755,"['CALM1', 'CALM2', 'ACTG1', 'MAPK3']",0.9999958129031761,0,0,4
508,miRNA regulation of p53 pathway in prostate cancer WP3982,0.9478533610845304,0.4108933385841083,0.022005586316418455,"['CHEK2', 'PMAIP1']",0.9999958129031761,0,0,2
509,Sphingolipid Metabolism (integrated pathway) WP4726,0.9478533610845304,0.4108933385841083,0.022005586316418455,"['CERS4', 'PLPP3']",0.9999958129031761,0,0,2
510,miRNA regulation of DNA damage response WP1530,0.9480029488093521,0.5922439037740497,0.0316244422670555,"['CDKN1A', 'RAD51', 'GADD45B', 'CHEK2', 'CDK2', 'PMAIP1', 'CYCS', 'RAD9A']",0.9999958129031761,0,0,8
511,G1 to S cell cycle control WP45,0.9481519046941371,0.5748088360237893,0.030603140037403744,"['CDKN2D', 'CDKN1A', 'CDKN2A', 'CREB3L1', 'RPA3', 'CDK2', 'MCM4']",0.9999958129031761,0,0,7
512,PPAR signaling pathway WP3942,0.94901684595193,0.5530836959408388,0.028942166984799404,"['CYP27A1', 'CYP4A11', 'UCP1', 'LPL', 'ACSBG1', 'ANGPTL4']",0.9999958129031761,0,0,6
513,Fatty acid transporters WP5061,0.9500568085613207,0.32292757209479395,0.016544709018893926,['ACSBG1'],0.9999958129031761,0,0,1
514,miRNAs involved in DNA damage response WP1545,0.9500568085613207,0.32292757209479395,0.016544709018893926,['CDKN1A'],0.9999958129031761,0,0,1
515,Overview of nanoparticle effects WP3287,0.9500568085613207,0.32292757209479395,0.016544709018893926,['HMOX1'],0.9999958129031761,0,0,1
516,G Protein Signaling Pathways WP35,0.9500680001754751,0.6285833953834699,0.032197121302868885,"['GNAZ', 'GNA14', 'GNG3', 'PRKCH', 'PRKAR1A', 'ADCY4', 'AKAP5', 'CALM1', 'HRAS', 'GNG11', 'CALM2']",0.9999958129031761,0,0,11
517,Disruption of postsynaptic signaling by CNV WP4875,0.9533137345813263,0.4518666666666667,0.02160429759534996,"['ARC', 'YWHAG', 'MAPK3']",0.9999958129031761,0,0,3
518,DNA Replication WP466,0.954240616046889,0.4884150572713427,0.022877078615785834,"['POLD1', 'RPA3', 'CDK2', 'MCM4']",0.9999958129031761,0,0,4
519,Non-small cell lung cancer WP4255,0.9579423489876527,0.573357712589766,0.024635851483705607,"['CDKN1A', 'GADD45B', 'CDKN2A', 'PLCG2', 'CYCS', 'HRAS', 'EGFR', 'MAPK3']",0.9999958129031761,0,0,8
520,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9584977128057562,0.5545581242826693,0.023506666737281127,"['ACLY', 'GSK3A', 'RBP4', 'HMGCS1', 'LPL', 'HMGCR', 'ACSS1']",0.9999958129031761,0,0,7
521,MET in type 1 papillary renal cell carcinoma WP4205,0.9597051770515376,0.531315629354845,0.02185255964608649,"['CDKN1A', 'JUN', 'HGF', 'GAB1', 'HRAS', 'MAPK3']",0.9999958129031761,0,0,6
522,Nonalcoholic fatty liver disease WP4396,0.9597059608406108,0.6710411561941941,0.027598803610542403,"['CEBPA', 'XBP1', 'JUN', 'GSK3A', 'VCAM1', 'NDUFB11', 'NDUFB5', 'NDUFA4', 'COX7A1', 'COX7C', 'UQCRH', 'SOCS3', 'CASP7', 'LEP', 'LEPR', 'CYCS', 'UQCRFS1', 'CCL2']",0.9999958129031761,0,0,18
523,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9600243136672302,0.475526930029308,0.019399914339049723,"['FA2H', 'MAP1LC3A', 'ATG101', 'CP']",0.9999958129031761,0,0,4
524,Cardiac Hypertrophic Response WP2795,0.9663767656873247,0.4909069814659048,0.016789752288567536,"['NFATC2', 'CALM1', 'FGF2', 'CALM2', 'MAPK3']",0.9999958129031761,0,0,5
525,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9665151785084249,0.2825199866755496,0.009622143637669736,['ACSF2'],0.9999958129031761,0,0,1
526,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.9665151785084249,0.2825199866755496,0.009622143637669736,['EIF1AX'],0.9999958129031761,0,0,1
527,Intraflagellar transport proteins binding to dynein WP4532,0.9683668262100683,0.3615061646117961,0.011620366509100817,"['DYNLT3', 'DYNLL2']",0.9999958129031761,0,0,2
528,Nanoparticle-mediated activation of receptor signaling WP2643,0.9683668262100683,0.3615061646117961,0.011620366509100817,"['HRAS', 'EGFR']",0.9999958129031761,0,0,2
529,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9696125555670333,0.45168389463154385,0.013938384361105144,"['CYP27A1', 'HMGCS1', 'DHCR24', 'HMGCR']",0.9999958129031761,0,0,4
530,Nucleotide Excision Repair WP4753,0.9696125555670333,0.45168389463154385,0.013938384361105144,"['CETN2', 'POLD1', 'RPA3', 'POLE3']",0.9999958129031761,0,0,4
531,One-carbon metabolism and related pathways WP3940,0.9696125555670333,0.45168389463154385,0.013938384361105144,"['GPX4', 'GPX3', 'GAD1', 'SOD3']",0.9999958129031761,0,0,4
532,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9725825640194115,0.26588156914997846,0.007391589609242078,['MAP1LC3A'],0.9999958129031761,0,0,1
533,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9725825640194115,0.26588156914997846,0.007391589609242078,['IGFBP7'],0.9999958129031761,0,0,1
534,EGF/EGFR signaling pathway WP437,0.9727021764095977,0.6581822541849067,0.018216728512897767,"['VAV3', 'JUN', 'LIMK2', 'GAB1', 'FOXO4', 'ELK1', 'FOXO1', 'EPN1', 'VAV1', 'EGFR', 'EPS8', 'GJA1', 'PLSCR1', 'RPS6KA5', 'INPP5D', 'NEDD4', 'FOSB', 'HRAS', 'AP2M1', 'ARF6']",0.9999958129031761,0,0,20
535,Insulin Signaling WP481,0.9727021764095977,0.6581822541849067,0.018216728512897767,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'SHC3', 'STXBP2', 'GAB1', 'ELK1', 'FOXO1', 'GYS2', 'SOCS3', 'RPS6KA5', 'RHOJ', 'MAP3K8', 'SGK1', 'HRAS', 'ARF6', 'MAPK3']",0.9999958129031761,0,0,20
536,Autophagy WP4923,0.9732786926053442,0.3475764488760157,0.00941404266844428,"['ATG101', 'ATG9A']",0.9999958129031761,0,0,2
537,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9735563710966736,0.4406346831057507,0.011808811332405557,"['EIF4A2', 'RPS6KA5', 'PIM1', 'MAPK3']",0.9999958129031761,0,0,4
538,MAPK Signaling Pathway WP382,0.973573182283053,0.7100758895928292,0.019017453135816285,"['HSPB1', 'ELK1', 'FGF2', 'EGFR', 'RPS6KA5', 'FGF8', 'MKNK2', 'MAP3K8', 'CD14', 'CACNG1', 'HRAS', 'CACNG5', 'MAPK3', 'DUSP4', 'NTRK1', 'JUN', 'DUSP2', 'DUSP3', 'PLA2G4D', 'IL1R1', 'BDNF', 'PLA2G4E', 'IL1R2', 'NFATC1', 'DUSP6', 'TGFBR2', 'FGF17', 'NR4A1', 'FGFR4', 'HSPA1B', 'HSPA1A', 'FGF10']",0.9999958129031761,0,0,32
539,Cell cycle WP179,0.9753811795061641,0.60718789407314,0.015135330768121406,"['CDKN2D', 'CDKN1A', 'GADD45B', 'YWHAB', 'CDKN2A', 'TTK', 'CDC14A', 'PTTG1', 'CHEK2', 'CDK2', 'MCM4', 'YWHAG', 'SKP1', 'YWHAH']",0.9999958129031761,0,0,14
540,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.9770159066352598,0.4301116245097572,0.010001104299386054,"['PPP1R15A', 'XBP1', 'MAP1LC3A', 'PPP1R1C']",0.9999958129031761,0,0,4
541,7q11.23 copy number variation syndrome WP4932,0.9771717471800413,0.5704445571331981,0.013173191749416606,"['CLDN5', 'ATP5F1B', 'BCL7B', 'BTK', 'FZD9', 'HMGA1', 'EIF4H', 'ATP5MC3', 'VPS37D', 'ACACB', 'MAPK3']",0.9999958129031761,0,0,11
542,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9775507726988361,0.25109186468280403,0.00570105261195065,['CASP7'],0.9999958129031761,0,0,1
543,PPAR-alpha pathway WP2878,0.9775507726988361,0.25109186468280403,0.00570105261195065,['CYP4A11'],0.9999958129031761,0,0,1
544,AMP-activated protein kinase (AMPK) signaling WP1403,0.9781023314783821,0.4836979836979837,0.010709547870439972,"['GYS2', 'CDKN1A', 'LEP', 'LEPR', 'HMGCR', 'ACACB']",0.9999958129031761,0,0,6
545,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9783472044643546,0.5232682490140572,0.011454685842105588,"['FZD2', 'CISH', 'LRP5', 'CALM1', 'FGF2', 'CALM2', 'AGT', 'MAPK3']",0.9999958129031761,0,0,8
546,DNA IR-double strand breaks and cellular response via ATM WP3959,0.980057724730876,0.4515010006671114,0.009094948686168362,"['YAP1', 'RAD51', 'CDKN2A', 'CHEK2', 'RAD9A']",0.9999958129031761,0,0,5
547,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9826956684382665,0.41050046985358757,0.007165614692970467,"['ARC', 'BDNF', 'HRAS', 'MAPK3']",0.9999958129031761,0,0,4
548,DNA IR-damage and cellular response via ATR WP4016,0.9827925613029459,0.5084530555620871,0.008825325060038816,"['SEM1', 'FEN1', 'RAD51', 'BCL6', 'CHEK2', 'CDK2', 'FOXM1', 'RAD9A']",0.9999958129031761,0,0,8
549,Glycerolipids and Glycerophospholipids WP4722,0.9849499070607372,0.2259493670886076,0.003426408020162002,['CDIPT'],0.9999958129031761,0,0,1
550,Fatty acid beta-oxidation WP143,0.9865165843940591,0.30114406309008107,0.004088073513322268,"['TPI1', 'LPL']",0.9999958129031761,0,0,2
551,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9870276085162213,0.3925946329936066,0.005126213254203618,"['NDUFB11', 'NDUFB5', 'NDUFAF4', 'TMEM70']",0.9999958129031761,0,0,4
552,Immune response to tuberculosis WP4197,0.9876773698816556,0.2151740109768091,0.0026679819961138804,['OAS1'],0.9999958129031761,0,0,1
553,Nanoparticle triggered autophagic cell death WP2509,0.9876773698816556,0.2151740109768091,0.0026679819961138804,['MAP1LC3A'],0.9999958129031761,0,0,1
554,Eukaryotic Transcription Initiation WP405,0.9881527391135405,0.34735897435897434,0.004139823887603192,"['TAF13', 'POLR2E', 'POLR2K']",0.9999958129031761,0,0,3
555,Proteasome Degradation WP183,0.9883799475183944,0.41793294294962074,0.004884839060576039,"['PSMD8', 'H2AFZ', 'NEDD4', 'HLA-E', 'PSMB9']",0.9999958129031761,0,0,5
556,Pyrimidine metabolism WP4022,0.9892585871805132,0.48119309961046186,0.0051966536650761945,"['CDA', 'RRM2', 'POLD1', 'POLE3', 'POLR2E', 'CMPK2', 'UPB1', 'POLR2K']",0.9999958129031761,0,0,8
557,ATM Signaling Network in Development and Disease  WP3878,0.9898798611691176,0.33865,0.003444644705363243,"['CHEK2', 'HSPB1', 'CDK5R1']",0.9999958129031761,0,0,3
558,Integrated Cancer Pathway WP1971,0.9898798611691176,0.33865,0.003444644705363243,"['CDKN1A', 'CHEK2', 'CDK2']",0.9999958129031761,0,0,3
559,Interleukin-11 Signaling Pathway WP2332,0.9898798611691176,0.33865,0.003444644705363243,"['SOCS3', 'HRAS', 'MAPK3']",0.9999958129031761,0,0,3
560,Retinoblastoma gene in cancer WP2446,0.9904743150642172,0.4748264651612336,0.00454472765807576,"['ANLN', 'CDKN1A', 'RRM2', 'H2AFZ', 'RPA3', 'CDK2', 'MCM4', 'TTK']",0.9999958129031761,0,0,8
561,Pancreatic adenocarcinoma pathway WP4263,0.9915599003703993,0.4686251978405568,0.0039720291988922666,"['CDKN1A', 'RAD51', 'GADD45B', 'CDKN2A', 'DUSP6', 'EGFR', 'TGFBR2', 'MAPK3']",0.9999958129031761,0,0,8
562,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.991641901233226,0.3684765670189383,0.0030927061920733453,"['IFIH1', 'NFKBIA', 'CASP10', 'IRF7']",0.9999958129031761,0,0,4
563,MTHFR deficiency WP4288,0.9917391255798061,0.19643426121715957,0.0016294584444707105,['CYCS'],0.9999958129031761,0,0,1
564,Glycosylation and related congenital defects WP4521,0.9932362696006768,0.1882356206973129,0.0012775002102528097,['MGAT2'],0.9999958129031761,0,0,1
565,Signal Transduction of S1P Receptor WP26,0.9932362696006768,0.1882356206973129,0.0012775002102528097,['MAPK3'],0.9999958129031761,0,0,1
566,Histone Modifications WP2369,0.9937243140270503,0.314953488372093,0.0019827773611598913,"['SET', 'SMYD1', 'HIST1H3E']",0.9999958129031761,0,0,3
567,Integrated breast cancer pathway WP1984,0.994776724468089,0.5459617940367857,0.0028591825467991065,"['JUN', 'GSK3A', 'ODC1', 'HMGCR', 'SMAD6', 'JAKMIP1', 'TFPI', 'FOXO1', 'EGFR', 'FOSL2', 'TGFBR2', 'RAD51', 'CHEK2', 'CDK2', 'RHO', 'FAU']",0.9999958129031761,0,0,16
568,Rett syndrome causing genes WP4312,0.9954542939554457,0.30091111111111113,0.0013709718402730047,"['CECR2', 'TBL1X', 'GABRD']",0.9999958129031761,0,0,3
569,Glycerophospholipid Biosynthetic Pathway WP2533,0.9962873882061202,0.16728353936881585,0.0006222145777928676,['CDIPT'],0.9999958129031761,0,0,1
570,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9969601318549971,0.16129723041781668,0.0004910690839887659,['ACTA2'],0.9999958129031761,0,0,1
571,Fragile X Syndrome  WP4549,0.9971602751543279,0.4675360710321865,0.001329562487714126,"['GABRA1', 'ARC', 'DUSP3', 'PRKAR1A', 'BDNF', 'CDKN2A', 'GAD1', 'GAB1', 'AKAP5', 'GABRD', 'AP2M1']",0.9999958129031761,0,0,11
572,Splicing factor NOVA regulated synaptic proteins WP4148,0.9972224625528103,0.23149548441117918,0.0006438819945060431,"['STXBP2', 'NCDN']",0.9999958129031761,0,0,2
573,Joubert Syndrome WP4656,0.9986476115102929,0.32671539480426565,0.0004421451828056295,"['TMEM17', 'CETN2', 'PDE6A', 'ARR3', 'ZNF423']",0.9999958129031761,0,0,5
574,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9987659312491467,0.43834591358667363,0.0005412830530090063,"['SLCO1C1', 'GSK3A', 'RPS6KA5', 'SHC3', 'TRIP10', 'LPL', 'MAP3K8', 'CYP3A4', 'HRAS', 'FOXO1', 'MAPK3']",0.9999958129031761,0,0,11
575,Thermogenesis WP4321,0.9990407052112944,0.3833907576457216,0.00036796127574603244,"['KLB', 'ADCY10', 'CREB3L1', 'PRDM16', 'UCP1', 'ADCY4', 'HRAS', 'ACTG1']",0.9999958129031761,0,0,8
576,Ciliopathies WP4803,0.9994688510649972,0.477733590087073,0.00025381510036871476,"['EVC2', 'DNAH11', 'RSPH4A', 'DNAAF3', 'CCDC114', 'DCDC2', 'GLI3', 'GLI2', 'RP1L1', 'TMEM17', 'ZIC2', 'MAK', 'NEK2', 'CCDC65', 'ZNF423', 'CCDC151', 'CCNO']",0.9999958129031761,0,0,17
577,Ciliary landscape WP4352,0.9996672195982137,0.4965159377316531,0.0001652582721340931,"['YAP1', 'DOCK5', 'TFAP2C', 'WHRN', 'DYNLT3', 'USH1C', 'COPS7A', 'DYNLL2', 'PSMD8', 'EXOSC4', 'ARHGDIA', 'GID8', 'CDH23', 'NEFL', 'MCM4', 'STOM', 'NEFM', 'VIM', 'CALM1', 'COPS8', 'CALM2']",0.9999958129031761,0,0,21
578,Energy Metabolism WP1541,0.9998960534834095,0.10023687911762529,1.0419815979351426e-05,['FOXO1'],0.9999958129031761,0,0,1
579,DNA Repair Pathways Full Network WP4946,0.9999721008738994,0.2810831108144192,7.84208254748624e-06,"['FEN1', 'NEIL2', 'RAD51', 'CETN2', 'POLD1', 'RPA3', 'POLE3']",0.9999958129031761,0,0,7
580,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999936582156704,0.1817036655316082,1.1523291126083724e-06,"['EVC2', 'TMEM17', 'CDK20', 'TULP3']",0.9999958129031761,0,0,4
581,mRNA Processing WP411,0.9999958129031761,0.10945528455284553,4.5830083378885356e-07,"['U2AF1L5', 'NCBP2', 'SNU13']",0.9999958129031761,0,0,3
